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ABSTRACT  
Background 
Living kidney donation represents more than one in three kidney transplants in the UK. The 
medical outcomes for living donors are well known. However, there is limited research 
regarding the psychosocial outcomes for living kidney donors. Understanding the 
psychosocial outcomes of living kidney donation will facilitate informed consent and guide 
the development of services that maintain the long-term health of donors.  
Aims 
To systematically review prospective studies reporting on the quality of life of kidney donors 
following live kidney donation in comparison to quality of life pre- donation. To discuss the 
factors associated with poor psychosocial outcome.  
Methods 
All relevant computerised databases were search. Citations in all relevant publications were 
searched. Unpublished datasets were obtained from key researchers. Inclusion in this review 
was limited to English language publications and studies with a prospective study design.  
Results 
Thirteen articles meeting the inclusion criteria were reviewed. These studies indicated that 
live kidney donation causes short term changes in quality of life. However, for the majority 
of donors, postoperative quality of life does not differ significantly from preoperative quality 
of life and the changes are not clinically or socially relevant. Current and past psychiatric 
symptoms were found to be an indicator of psychosocial outcome following donation.   
Conclusions  
More research investigating the psychosocial outcomes of living kidney donors is required. 
Future studies should be of prospective design, should assess preoperative quality of life at a 
time reflecting premorbid functioning, and where possible, have a suitable comparison group.   
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1. INTRODUCTION 
 
End-stage kidney disease (ESRD) is the complete, or almost complete, failure of the kidneys 
to function. The kidneys can no longer remove waste, concentrate urine, and regulate many 
other important body functions. Patients who have ESRD need dialysis1 or a kidney 
transplant. Kidney transplantation is preferential because of superior quality of life and 
survival rates (Hariharan et al, 2000). Renal transplantation from a live donor poses the best 
outcome for individuals with ESRD. The survival rates for a living kidney graft at one year 
range from 88.8% to 93.9% in comparison to 75.7% to 87.7% for cadaveric2 grafts 
(Hariharan et al, 2000). The mean lifespan for a living graft is also superior, on average 21.6 
years in comparison to 13.8 years for a cadaveric graft (Hariharan et al, 2000).  
	  
The Human Tissue (Scotland) Act (2006) permitted donations from non-related donors and 
withdrew previous restrictions prohibiting individuals obtaining anything in return for 
donating and thus led to the introduction of new types of donor-recipient relationships; The 
non-directed altruistic donation involving donation to an unidentified recipient. The paired 
donation in which a donor who is incompatible with their chosen recipient donates to an 
anonymous recipient with whom they are more compatible, and in turn, the donor for this 
recipient donates to the original donors desired recipient. The pooled donation which is a 
similar process but involves three or more donor and recipient pairs.  Consequently in the 
UK, the number of living donor kidney transplants is increasing – 475 in 2004-05, 589 in 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Dialysis is the artificial process of getting rid of waste and unwanted water  from the blood. 
2 Kidney graft from a deceased donor.  
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2005-06, 690 in 2006-07, 831 in 2007-08, 927 in 2008-09 and 1,038 in 2009-10 – and now 
represent more than one in three of all kidney transplants (NHS blood and Transplant 
statistics).  
 
The medical outcomes for living kidney donors has been well established.	  Kidney donors do 
not experience any long-term medical complications following donation; the life expectancy 
of donors is similar to that of non-donors and the risk of end stage renal failure does not 
increase (Ibrahim et al, 2009). The potential of having complications associated with the 
donation process is also low; the risk of death and serious surgical complications is 0.005% 
and 0.3% respectively (Nolan et al, 2004). However, research evaluating the impact of organ 
donation on the donors’ psychological wellbeing is limited. It is imperative that the 
psychological outcomes for donors are investigated in order to facilitate informed consent 
and guide the development of services that maintain the long-term health of donors.  	  
 
This review aims to systematically review prospective studies reporting on the psychosocial 
outcome of live kidney donors.  There are two published reviews in this area, Clemens et al 
(2006) and Ku et al (2005). With respect to Clemens et al (2006) the author did not calculate 
effect sizes or present the results in table format to allow the reader to summarise and quickly 
compare the findings of the individual studies.  Clemens et al (2006) also reviews both 
prospective studies and retrospective studies. Prospective studies identify study participants 
before donation and then compare their quality of life after donation with their pre-transplant 
quality of life and in some cases population norms. The study design allows the researcher to 
identify an exact period at which postoperative quality of life will be assessed. Retrospective 
studies identify individuals who have already donated and then ask them to report on their 
perception of their quality of life during the postoperative period. Such reports are then 
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compared to population norms. With a retrospective study design donors may have donated 
many years earlier and therefore their recall of the postoperative period may be subject to 
recall bias. Furthermore, comparing donors’ postoperative quality of life to only population 
norms, as in the retrospective study design, introduces limitations. Several studies (Bergman 
et al, 2005; Smith et al, 2004 and Walton-Moss et al, 2007) have found that preoperatively 
donors score higher on quality of life rating scales than the general population. Thus it is 
possible that donation impacts negatively on donors’ psychosocial health yet their scores on 
health-related quality of life questionnaires will remain comparable with population norms.  
Finally, since the publication of Clemens et al (2006) six prospective studies have been 
published (Aguiar et al, 2007; Minnee et al, 2008a and b; Pace et al 2003; Virzi et al, 2007; 
Walton-Moss et al, 2007).  With respect to Ku et al (2005), the reviews limits itself to 
reviewing studies using the Short Form Health Survey (SF-36) (Ware et al, 1994) thus 
missing data from, Lumsdaine et al (2005), Minz et al (2005), Pace et al (2003) Simmons et 
al (1977), Taghavi et al (2001) Varma et al (1992), Yoo et al (1996).  Since the publication of 
this study, seven studies of the psychosocial outcomes of living kidney donors have been 
published (Aguiar et al, 2007; Bergman et al, 2005; Kok et al, 2006; Minnee et al, 2008 a &b; 
Virzi et al, 2007; Walton-Moss et al, 2007). This study also reviews both prospective studies 
and retrospective studies. Furthermore, The Centre for Reviews and Dissemination suggest 
that it is essential to appraise the quality of the studies included in a review as this will impact 
upon the reliability of the results and therefore the conclusion drawn. Neither study has 
formally appraised the studies included in their review 
2. METHOD 
Aims 
To systematically review prospective studies reporting on the quality of life of donors 
following live kidney donation in comparison to quality of life pre- donation.  
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Search criteria  
The computerised databases searched were: Ovid Medline (1950-papers in process as of 
December 2010), Embase (1980- December 2010), Web of Knowledge Medline, EBSCO 
databases including IBSS, Medline, PsychInfo, PsychArticles, Psychology and Behavioural 
Sciences collection (1898-December 2010). Searches were limited to English language. 
Citations in all relevant publications were also searched.   
 
The following terms were combined for electronic search: 
• ( live donor* or living donor* or living donation or live donation)  
• (kidney or renal)  
• ( adaptation or social adjustment* or psychosocial* or psychological* or behavio*ral* 
or quality of life or activities of daily living or mental disorder* or depressi* or anxiety or 
mood disorder* or psychiatric diagnosis )	  
	  
Inclusion criteria 
• Studies reporting on postoperative psychosocial outcomes for live kidney donors 
• Prospective design 
• Postoperative outcomes compared to preoperative data. 
• Unpublished data were included only if a subset of the data had been published in a 
peer reviewed journal  
• English language. 	  
	  
Exclusion criteria 
Qualitative studies, reviews with no new empirical data, conference abstracts and 
dissertations were excluded. In the case where authors had used the same dataset in more than 
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one publication, the reviewer included the whole dataset where obtained from the author or 
included the most recent publication.  
Data on the number of days before live kidney donors returned to work were excluded 
because this outcome is influenced by many confounding factors such as type of 
employment, presence or absence of disability allowance and personal characteristics. Data 
on the length of hospital stay were excluded as this is influenced both by the surgeon who 
carries out the procedure and hospital policy.  This review focuses on psychosocial outcomes 
for donors and therefore data reporting on the physical outcomes of donors are excluded. This 
includes physical component summary scale data from the SF-36 (Ware et al, 1994) and the 
World Health Organisation Quality of Life questionnaire. The one exception to this rule is 
that studies that reported the correlation between physical wellbeing and quality of life are 
discussed with the aim of understanding whether quality of life is affected by psychological 
wellbeing, physical disability or pain.  
 
The quality of articles was assessed using a checklist derived from the Scottish Intercollegiate 
Guidelines Network (SIGN) guidelines for assessing the quality of cohort studies (SIGN 50). 
Articles were scored on the following criteria: Study rationale, sampling procedures, 
assessment method, consideration of confounding factors and statistical analysis. The total 
score was used to rank studies according to their methodological quality using the following 
criteria: <50% poor quality, 50-75 moderate quality, >75% good quality. A randomly 
selected twenty-five percent of the included studies were rated by a second researcher, who 
was a trainee Clinical Psychologist in their third year of training.  Any minor discrepancies in 
quality rating were discussed in order to reach consensus.   
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A copy of the quality criteria data collection sheet can be seen in Appendix 2. Scoring for 
each article can be seen in Table 1. Table 2 details the quality ranking for each study.  
Search Results 
Seven papers were excluded from the review despite meeting the inclusion and exclusion 
criteria. Smith et al (2003) was superseded by Smith et al (2004) due to an overlap in the 
dataset.  Minnee et al (2008a & b) were superseded by a larger dataset obtained from the 
author, thereafter referred to as Minnee et al (unpublished). Wolf et al (2001) was excluded 
because only the postoperative results were published and preoperative data could not be 
obtained from the author. Pace et al (2003) was excluded because although the study 
examined the psychosocial outcome of individuals who underwent a nephrectomy, the 
sample included individuals who underwent nephrectomy for medical reasons.  
Details of the fourteen included studies are presented in Table 2.  
 
 Statistical Analysis 
Effect sizes were recorded or calculated from the available data. Effects size was calculated 
using the Glass’ method (Glass &Hopkins, 2008) whereby the effect size is calculated using 
the following equation: mean at follow-up subtracted by the mean at baseline divided by the 
standard deviation for the baseline. This method was chosen because the study by Smith et al 
(2003 & 2004) was the only prospective study to calculate effect size and did so using 
Glass’s method. To maintain consistency and allow comparison between publications, further 
calculations were undertaken using the same method. Effect sizes were classified as follows: 
0.2-0.49 equates to a small difference, 0.5-0.79 equates to a moderate difference and 0.8 or 
above equates to a large difference (Cohen, 1988).   
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The results of the SF-36 were also assessed using the following directive: a difference of 5-
points in any domain was considered minimally clinically and socially significant and a 
difference of ten-points was considered moderately clinically and socially significant (Ware 
et al, 1994).  
 
Where publications presented their results in graph or boxplot format (Kok et al, 2006; 
Lumsdaine et al, 2005) and the exact data were not obtained, clinical significance and effect 
sizes were not calculated due to the possibility of inaccuracy.  
 
3. RESULTS 
3.1 Studies reporting on quality of life 
Seven studies (Aguiar et al, 2007; Bergman et al, 2005; Kok et al, 2006; Minnee et al, 
unpublished; Smith et al, 2004; Virzi et al, 2007; Walton-Moss et al 2007) measured quality 
of life using the SF-36 (Ware et al, 1994). The SF-36 assesses 4 components of mental 
health: (1) energy and fatigue (vitality domain) (2) limitations on social functioning because 
of physical or emotional problems (social functioning domain); (3) limitations on usual 
activities because of emotional problems (role-emotional domain) and (4) psychological 
distress and well-being (mental health domain). Each of the dimension scores are expressed 
as a value between 0 and 100, with greater scores representing better health. The results can 
be represented in terms of the four domains or as an overall representation of general mental 
health in the Mental Health Component Summary Scale (MCS).  
 
Results for the studies measuring postoperative quality of life using the SF-36 are presented 
in Tables 3 to 7. With the exception of Bergman et al (2005), the results presented represent 
the mean scores and standard deviations. Bergman et al (2005) reported the MCS as a mean 
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and standard deviation but the four corresponding domains as medians and interquartile 
ranges (IQR).   
 
Bergman et al (2005) compared living kidney donors preoperative health related quality of 
life with their health related quality of life one month after donation (median follow-up 
period 29 days, IQR 22-30 days). The results suggested a non-significant improvement in 
overall psychological wellbeing following donation, as measured by the MCS (table 3). With 
respect to the individual SF-36 domains, Bergman et al (2005) reported a significant decline 
in the domains of vitality and social functioning one month post-transplant and a non-
significant increase in the domain of mental health (tables 4, 5 and 7 respectively). This paper 
benefits from having a reference group, SF-36 scores for adults aged 35-44 years living in 
Montreal, which allows the reader to note that, preoperatively, donors scores on the vitality 
and social functioning domains were above that of the reference group, but, following 
donation fell below the scores for the reference group; donors postoperative scores vs. 
reference group scores3: vitality 60 (40-85) vs. 65 (50-75); social functioning 87.5 (62.5-100) 
vs. 100 (75-100). This paper is limited by the author only reporting changes in the SF-36 
scores for the group as a whole and not reporting on how many donors had a significant 
improvement or decline in any of the SF-36 domains following donation. The author did note 
however, that one donor experienced a major depressive episode in the weeks following 
donation. As the results were reported as medians and not means, this donor’s lower post-
operative mental health domain score cannot account for the post-operative increase in the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 Results presented as median  (Interquartile range) 
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mental health domain score failing to reach statistical significance for the group as a whole. 
However it does highlight that individual responses to living kidney donation vary and that 
reporting psychosocial outcomes of living kidney donation at an individual donor level will 
assist in understanding the impact of donation for the majority and facilitate identification of 
the risk factors for poor psychosocial outcome.   
 
Smith et al (2004) compared pre-operative health related quality of life with health related 
quality of life at four- and twelve-months post-transplant. The authors found that donation 
was associated with a significant reduction in overall mental health, as measured by the MCS, 
with a moderate effect size four- and 12-months posttransplant (table 3). This paper benefits 
from having a reference group, SF-36 scores for adults from the State of Victoria, and thus 
allows the reader to note that, pre-donation, donors MCS scores were significantly higher 
than the population norm scores; donors mean preoperative MCS score vs. population norm 
MCS score: 54.7, sd 6.0 vs. 50.1, sd 9.0; t=3.23, df=4.960, P=0.001). However at four - and 
twelve months this difference was no longer statistically significant. It is important to note 
that this result was obtained when the author compared the pre-operative and post-operative 
scores for the group as a whole. A strength of this paper is that the author analysed the 
difference in pre- and post-operative SF-36 scores for each individual and in doing so found 
that for only 19% of the sample was the decrease in the MCS scores at 12-months large and 
clinically and socially relevant. Whereas for 10% of the sample there was an improvement in 
psychosocial functioning that was better than would be expected for the group. With respect 
to the individual SF-36 domain scores, Smith et al (2004) found that all post-operative 
domain scores were lower than preoperative scores one year post-transplant (tables 4-7). It is 
important to note that although only vitality reached statistical significance (table 4), both 
social functioning and role emotion were clinically and socially relevant with a moderate and 
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large effect size respectively (table 5 and 6 respectively). The results of this study differ from 
that of the other studies in that Smith et al (2004) found that the adverse affects of living 
kidney donation can last up to one year for some donors. By comparison, the majority of 
studies, discussed hereafter, indicate that post-operative SF-36 scores begin to return to 
baseline scores between three and six months postoperative, indicating the start of recovery. 
The difference in the results reported by Smith et al (2004) may be attributed to differences in 
the methodology. Pre-operative health related quality of life was assessed by an interview 
with a psychiatrist and a review of medical records in addition to the SF-36 questionnaire 
completed by the participant. Thus the preoperative assessment in this study is potentially 
more reliable as donors are more likely to underreport mental health concerns in a self report 
assessment due to concerns that doing so may prevent them from donating. Furthermore, the 
majority of the participants (n=85%) in this study underwent open donor nephrectomy, 
whereby the kidney is removed through an large open incision, this type of surgery is 
associated with a higher rate of complications, prolonged postoperative pain, and a slower 
recovery pace (Antcliffe et al, 2009; Bergman et al, 2005; Minnee et al, 2008a; Nanidis et al, 
2008).  By comparison, all of the participants in Bergman et al (2005) and Walton- Moss et al 
(2007) and 55% of the participants in Kok et al (2006) underwent laparoscopic donor 
nephrectomy, which involves removal of the kidney through a small incision using 
laparoscopic techniques. This type of surgery is associated with better psychosocial outcomes 
(Nanidis et al, 2008). Finally, over half (52%) of the participants in Smith et al (2004) were 
caregiver to the recipient, therefore in this study donors may have taken longer to recover 
because they were unable to fully rest due to having to care for the recipient or having 
reduced practical support from other family members who may have been caring for the 
recipient. The fact that the majority were caring for the recipient following surgery may also 
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explain the reduction in usual activities (role-emotion) and social functioning (social 
functioning domain).  
 
Contrary to the results of Smith et al (2004), several studies have reported post-operative 
recovery between three and six months. Aguiar et al (2007) compared health related quality 
of life preoperatively with health related quality of life one- and three- months following 
donation. The authors aimed to compare the outcome of live kidney donation as a 
consequence of surgical access, either lombotomy incision (incision made below the ribs) or 
subcostal incision (incision made in front the eleventh rib) however to the papers benefit, the 
authors analysed inner group comparison as well as inter group comparison. The study also 
benefits from a random allocation of participants to surgical access and a blind assessment of 
outcome. Furthermore, the paper controlled for several confounding factors; the same 
surgeon performed the nephrectomy, the same anesthetic procedures were given to each 
donor and all donors were biologically related to the recipient. The results indicated that there 
was a significant decrease in all the SF-36 domain scores one month following surgery, 
however, this was partially recovered by three months posttransplant when scores were close 
to baseline (tables 4 to 7). Unfortunately the authors compared only the pre-operative and 
post-operative mean for the group and did not report on the difference at an individual donor 
level. As Smith et al (2004) has shown the impact of donation differs significantly between 
each individual donor with some donors having poor psychosocial outcome whilst others 
show improvement in their SF-36 scores. Similar results were found by Kok et al (2006); all 
SF-36 domain scores were significantly lower one month post transplant but showed the start 
of recovery at three months post transplant (tables 5 to 7) . The exception being vitality which 
remained significantly lower three months posttransplant but had returned to pretransplant 
levels by six months posttransplant (table 4). However, the result of Kok et al (2006) are 
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limited by the preoperative data being gathered the evening before surgery and therefore not 
reflecting premorbid functioning but potentially reflecting increased psychological distress 
due to impeding surgery. Walton-Moss et al (2007) also found that at three months post 
transplant all SF-36 domains scores were lower and that recovery began at six months 
posttransplant, however scores remained lower than baseline and with the exception of 
mental health were moderate clinically and socially relevant is possible that the preoperative 
assessment gathered in this study is more reliable and reflective of premorbid functioning as 
the preoperative data was gathered during the initial evaluation at the outpatient clinic. The 
results of  Minnee et al (unpublished) concur but only for older donors4; vitality, social 
functioning and role emotion decreased three month post transplant and  remained lower at 
six months post transplant with moderate to large effect sizes (tables 4, 5 and 6 respectively). 
With respect to younger donors however six months post transplant, social functioning, role 
emotion and mental health domain scores surpass pretransplant scores (tables 5, 6 and 7 
respectively) and vitality was only slightly reduced (table 4). Unfortunately the results of this 
study are limited by the author not defining when the preoperative data was gathered and 
therefore the reader is left unsure of whether the preoperative SF-36 scores are representative 
of premorbid functioning. Virzi et al (2007) support this finding; the pre-operative scores on 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 Minnee et al (unpublished) analysed older (≥55 years) and younger donors separately as the purpose of this 
study was to examine surgical outcome and quality of life in older live kidney donors.  
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the domains of social functioning and mental health were higher than baseline (tables 5 and 7 
respectively) and the domain of vitality was only marginally decreased (table 4). This study 
does not have the limitation of Kok et al (2006) and Minnee et al (unpublished) as the 
preoperative data was gathered one month before donation. However as 67% (n=32) of the 
donors were donating to their child it is possible that improvement in SF-36 domain scores do 
not reflect the positive effects of donation but rather reduced psychological distress in parents 
as a consequence of improved health and successful transplantation in their children.  
 
There are six other studies measuring quality of life following kidney donation which used a 
variety of measurements (table 8). Varma et al (1992) administered the Dysfunctional 
Analysis Questionnaire in which a score of forty is indicative of functioning at the 
pretransplant level. The results suggested only mild, non-significant dysfunction in social 
(42.3), vocational (44.3) and personal (42.5) functioning and premorbid levels for familial 
(39.2) and cognitive (40.5) functioning. Lumsdaine et al (2005) administered the WHO 
Quality of Life Questionnaire six weeks and twelve months posttransplant and reported that 
although donors psychological domain scores marginally decreased posttransplant, the scores 
remained significantly higher than UK norms (UK population norms: median 14.6, IQR 12.0-
7.5; p<0.001). However the retention rate in this study was low (77%) and the author did not 
report on the status of those who dropped out of the study despite the author being part of the 
renal team and having access to this information from clinic appointments. Consequently the 
reader is unable to determine if those who dropped out of the study did so because they were 
having difficulty functioning whereas those who remained in the study represent donors with 
better psychosocial outcomes.   
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Simmons et al (1977) reported that the majority of donors (53%) had increased self esteem 
and happiness one year after successful donation. It has been suggested that this result was 
obtained because only donors involved in a successful transplantation were included in the 
analysis and as the donors were closely related to the recipient any increase in wellbeing is 
consequential to removal of kidney disease in their family member and removal of the 
impending fear of the operation. However the author argues that when compared with other 
control groups such as population norms and family member who decided not to donate, 
pretransplant the donors scores are equivalent but posttransplant considerably higher. These 
results were corroborated by Simmons et al (1982) who found that 51% of donors had higher 
scores on the Rosenberg self esteem questionnaire posttransplant.   
 
3.2 Prevalence of psychiatric morbidity pre- and post- transplant 
The MCS score is useful in screening for psychiatric disorders (Ware et al, 1994). For 
example, using a cut-off score of 42, the MCS has a sensitivity of 74% and a specificity of 
81% in detecting patients diagnosed with depressive disorder (Ware et al, 1994). The results 
of Smith et al (2004) and Bergman et al (2005) show that although postoperative MCS scores 
fell below preoperative scores, the average score did not suggest that donors met caseness for 
major depressive disorder. Similarly, Varma et al (1992), Virzi et al (2007) and Yoo et al 
(1996) reported that scores on psychometric assessments used to measures depressive 
symptoms scores did not increase significantly following donation (Table 9).  
 
With respect to prevalence, whilst Virzi et al (2007) reported a reduction in prevalence of 
depression, Minz et al (2005), Smith et al (2004) and Taghavi et al (2001) reported an 
increase (Table 9).  The prevalence of depression may increase following donation due to 
reduction in activity, disruption of family life and daily routine and concerns about the loss of 
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an organ. Depression may also be associated with the experience of pain or illness. Providing 
information on the correlation between MCS and Physical Component Summary Scores on 
the SF-36 would provide insight in this area. Unfortunately only Smith et al (2004) reports 
these data.   
  
With respect to anxiety, anxiety scores did not increase significantly following transplant 
(Minz et al, 2005; Varma et al, 1992; Virzi et al, 2007; Table 9). The above results however 
have not been replicated. Yoo et al (1996) found that donors were significantly more anxious 
about dying after donation, which may explain why donors experienced significantly more 
somatisation following donation (Varma et al, 1992). Similarly, Taghavi et al (2001) and 
Smith et al (2004) found that the prevalence of anxiety increased following donation. 
Smith et al (2004) reported a striking increase in the point prevalence (2%-15%) and the 
12month prevalence (10-31%) of psychiatric caseness between the preoperative period and 
the 12 month postoperative period indicative of high incidence. The preoperative point 
prevalence for any of the disorders assessed for the donors was lower than that for the 
Australian population (2% vs. 11%) but the 12 month point prevalence was higher (15%). 
Specifically for anxiety and depression the 12 month point prevalence for the Australian 
population was 12% which is lower than the 12 month point prevalence for the donors (18%) 
 
3.3 Factors that influence psychosocial outcome of live kidney donors  
Understanding the factors that lead to poorer psychosocial outcome after donation for some 
individuals will inform the psychological screening of potential donors and post-operative 
follow-up of donors.  The factors that increase the risk of poor psychosocial outcome 
reported in the included studies are discussed below.  
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The growing need for less invasive or less painful nephrectomy have led to a variety of 
surgical accesses to approach the kidney being developed. The introduction of laparoscopic 
donor nephrectomy (LDN)  aims to replace the traditional open door nephrectomy (ODN) 
which is associated with a higher rate of complications, longer hospital stays, prolonged 
postoperative pain, cosmetic consequences and slower recovery pace (Antcliffe et al, 2009; 
Bergman et al, 2005; Minnee et al, 2008a; Nanidis et al, 2008). Only Kok et al (2006) 
investigated the impact of surgical technique on health related quality of life. The results 
indicated that donors who underwent mini-incision donor nephrectomy (MIDN) did not have 
poorer outcomes than those that underwent LDN, with the exception that for individuals 
undergoing LDN, role emotion was not significantly affected by donation (table 6). This 
paper has several limitations. Firstly, donors whose LDN was converted to an MIDN due to 
complications were still analysed in the LDN group.  Secondly, the MIDN group had more 
female participants than the LDN group and females in the Dutch population are reported to 
have significantly lower SF-36 domain scores (Aaronson et al, 1998). Therefore as a 
consequence of the gender distribution one would expect scores for the MIDN group to be 
lower.    These results are also surprising as Minz et al (2005) found that prolonged 
hospitalisation and  persistent pain was associated with poorer psychosocial outcomes for 
donors and that postoperative depression was higher in those who believed that donation had 
a negative impact on their health (p<0.0001).  
 
Yoo et al (1996) found that non-related live kidney donors reported significantly more life 
satisfaction and psychological well-being after donation than those who were related donors 
(p<0.05). This may be because related donors are carers for the recipients and therefore have 
less time in pleasurable activities or less time to recuperate. However, Smith et al (2004) 
found that the relationship between the donor and recipient (carer or not) did not impact on 
	   -­‐	  25	  -­‐	  
the MCS scores at 12months. Therefore this may be explained by related donors being more 
affected by recipient reciprocity; Minz et al (2005) found that poor recipient reciprocity was 
associated with poor psychosocial outcome whilst Varma et al (1992) believed that the 
significant increase in somatisation following donation was the result of lack of attention paid 
to the donors after donation. 
 
The result of Smith et al (2004) suggest that current and past psychiatric symptoms are an 
indicator of psychosocial outcome following donation; donors preoperative Transplant 
Evaluation Rating Scale (TERS) score significantly correlated with MCS at 4-months 
postoperative (r=0.42, P=0.003) and 12- months (r=-0.28, P=0.049) postoperatively. TERS 
scores are a measure of past and present psychiatric symptoms and personality and of 
compliance, coping behaviour and social support. It is not surprising therefore that the 
American Society of Transplantation recommends that a formal psychosocial evaluation be 
given to donors before they are approved for donation.  
 
4. SUMMARY OF LIMITATIONS AND IMPLICATIONS FOR FUTURE 
RESEARCH 
Living kidney donors are a select sample of healthy individuals and as such pretransplant 
their scores on measurement of quality of life will be higher than that obtained from 
population norms (Walton-Moss et al, 2007).  Therefore, in order to give an accurate 
description of the psychosocial outcomes of live kidney donation it is essential to use a 
prospective study design in which quality of life is assessed pre- and posttransplant. However 
it may be argued that this methodology introduces confounding factors and limitations to 
interpreting results. For example, where psychological distress is not significantly greater 
after transplant one could argue that pretransplant donors are distressed despite not 
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encountering any stressful event at that time. This is possibly due to continuous concerns 
regarding their impending operation and subsequent recovery and in some, concerns about 
the health of the recipient. However posttransplant this anxiety abates, at least in those where 
there has been a successful transplant. Support for this hypothesis being that following 
donation trait anxiety scores significantly decreased possibly indicating that the experience of 
donation had lowered the individual’s propensity to interpret situations as threatening and 
experience anxiety (Minz et al, 2005). This may also explain why some studies find that 
donation results in increased happiness and decreased levels of distress, perhaps because the 
donors’ distress may be relieved due to improved health of the recipient and that fact that 
surgery is behind them. The only way to fully explore this area would be to compare post 
transplant functioning with donors’ premorbid functioning, before the onset of kidney disease 
in the recipient or at least before the donor consented to donate.  However as this would not 
be feasible it may be possible to further consider this confounding factors by including 
control subjects such as family members who are suitable for donation but chose not to 
donate.  
 
With the exception of Smith et al (2004), psychological well-being was assessed using a self-
report measure. It is possible that pretransplant donors underreport psychological problems 
and difficulties in functioning due to the desire to become a donor. Whereas following 
transplantation the donors do not have to meet an inclusion criterion and therefore donors 
provide more reliable reports. This hypotheses may be supported by the results of Smith et al 
(2004); in this study, current and past (last 12 months and lifetime) psychiatric caseness was  
established by a psychiatrist using information from a semi structured interview and medical 
records combined with information from the self- completed  patient health questionnaire. 
Furthermore donors and their families in this study were given an education session stressing 
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the importance of mental wellbeing and the implication of hiding symptomatology and were 
informed that the psychiatrist had access to medical records and interviews conducted over 
the preceding months. The results of this study in comparison to others indicates that live 
kidney donation has a negative impact on the quality of life for some donors which can last 
up to 12-months post transplant. Furthermore, unlike others, this study reported a striking 
increase in point prevalence and incidence post transplant. Unfortunately Smith et al (2004) 
did not report the accuracy of the self completed assessment in comparison to the review of 
medical records and assessment by the psychiatrist.  
 
Another limitation of the literature involves selection bias. It is possible that donors with 
adverse outcomes are less willing or able to participate. Bergman et al (2005) noted that 
although donors who withdrew from the study postoperatively did not differ with respect to 
demographic and intraoperative data, they did have a lower postoperative quality of life. This 
is an area that warrants further investigation. Unfortunately no other study reported on the 
outcome of those refused to participate in the study or were lost to follow up despite this 
possibly being obtainable from medical record or follow up clinic reports.  
 
7. CONCLUSIONS 
The literature reviewed suggests that live kidney donation causes short term changes in 
quality of life. However, for the majority of donors, postoperative quality of life does not 
differ significantly from preoperative quality of life and the changes are not clinically or 
socially relevant. Despite this, however, as donors are undergoing an unnecessary invasive 
procedure for the benefit of another, it is imperative in order to prepare for the posttransplant 
period that donors are aware of the psychosocial outcomes of live kidney donation. 
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Table 1: Quality rating for included articles.  
 Aguiar et al (2007) Bergman et al (2005) Kok et al (2006) Lumsdaine et al (2005) Minz et al (2005) 
The study addresses an appropriate and 
clearly focused question. 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
The main objective of the study is clearly 
defined 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
Selection of Subjects      
The sample is representative of the 
population being studied. 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
The study reports the sample size. Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
The study indicates how many of the 
people asked to take part did so 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 No  0/1 
The study reports the retention rate for 
each stage of follow up 
Yes 1/1 Yes 1/1 No  0/1 No  0/1 Yes 1/1 
Comparison is made between full 
participants and those lost to follow up. 
Yes 1/1 Yes 1/1 No  0/1 No  0/1 No  0/1 
The study states the inclusion and 
exclusion criteria. 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 No  0/1 
Assessment      
The outcomes are clearly defined. Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
The measure of assessment of outcome is 
stated and is reliable and valid 
Well covered 2/2 Well covered 2/2 Well covered 2/2 Well covered 2/2 Adequately covered 1/2 
Confounding Variables      
The main potential confounders are 
identified and taken into account in the 
design and analysis. 
Well covered 2/2 Adequately covered 1/2 Well covered 2/2 Well covered 2/2 No, poorly addressed  
0/2 
Statistical analysis      
The statistical analysis is appropriate given 
the study design and the outcome measures 
used 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
Are effect sizes, confidence interval and p-
values been reported where appropriate 
reported 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
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 Simmons et al (1977) Simmons et al (1982) Smith et al (2004) Taghavi et al (2001) 
The study addresses an appropriate and 
clearly focused question. 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
The main objective of the study is 
clearly defined 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
Selection of Subjects     
The sample is representative of the 
population being studied. 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
The study reports the sample size.  Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
The study indicates how many of the 
people asked to take part did so 
No  0/1 Yes 1/1 Yes 1/1 No  0/1 
The study reports the retention rate for 
each stage of follow up 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1  
Comparison is made between full 
participants and those lost to follow up. 
No  0/1 No  0/1 Yes 1/1 No  0/1 
The study states the inclusion and 
exclusion criteria. 
Yes 1/1 Yes 1/1 No  0/1 No  0/1 
Assessment     
The outcomes are clearly defined. No  0/1 Yes 1/1 Yes 1/1 Yes 1/1 
The measure of assessment of outcome 
is stated and is reliable and valid 
No, poorly addressed  
0/2 
Adequately addressed 
1/2 
Well covered 2/2 Well covered 2/2 
Confounding Variables      
The main potential confounders are 
identified and taken into account in the 
design and analysis. 
No, poorly addressed  
0/2 
No, poorly addressed  
0/2 
Well covered 2/2 Adequately covered 1/2  
Statistical analysis     
The statistical analysis is appropriate 
given the study design and the outcome 
measures used 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
Are effect sizes, confidence interval and 
p-values been reported where 
appropriate reported 
Yes 1/1 Yes 1/1 Yes 1/1 No  0/1 
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 Varma et al (1992) Virzi et al (2007) Walton-Moss et al (2007) Yoo et al (1996) 
The study addresses an appropriate 
and clearly focused question. 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
The main objective of the study is 
clearly defined 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
Selection of Subjects     
The sample is representative of the 
population being studied. 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
The study reports the sample size.  Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
The study indicates how many of the 
people asked to take part did so 
No  0/1 No  0/1 Yes 1/1 No  0/1 
The study reports the retention rate 
for each stage of follow up 
No  0/1 No  0/1 Yes 1/1 No  0/1 
Comparison is made between full 
participants and those lost to follow 
up. 
No  0/1 No  0/1 No  0/1 No  0/1 
The study states the inclusion and 
exclusion criteria. 
No  0/1 No  0/1 No  0/1 No  0/1 
Assessment     
The outcomes are clearly defined. Yes 1/1 Yes 1/1 Yes 1/1 No  0/1 
The measure of assessment of 
outcome is stated and is reliable and 
valid 
Well covered 2/2 Well covered 2/2 Well covered 2/2 Well covered 2/2 
Confounding Variables      
The main potential confounders are 
identified and taken into account in 
the design and analysis. 
Well covered 2/2 No, poorly addressed  0/2 Well covered 2/2 No, poorly addressed  0/2 
Statistical analysis     
The statistical analysis is appropriate 
given the study design and the 
outcome measures used 
Yes 1/1 Yes 1/1 Yes 1/1 Yes 1/1 
Are effect sizes, confidence interval 
and p-values been reported where 
appropriate reported 
Yes 1/1 Yes 1/1 No  0/1 Yes 1/1 
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Table 2: Characteristics of included studies 
       
Study Quality 
rating 
Type of 
nephrectomy 
No. included in 
analysis reported 
Demographics 
Gender (%M:F) 
Mean age 
(sd/range) 
Follow-up period Assessment: variable assessed 
Aguiar et al (2007) Moderate ODN 
 
N= 60 
Lombotomy access: 30 
Subcostal access: 30  
32:68 
41.6 (8.9)  
1 & 3 months  SF-36: QoL 
Bergman et al (2005) Good LDN 35 43:57 
40 (31-49) 
1 month SF-36: QoL 
Self –rated recovery 
Kok et al (2006) Good ODN 
LDN 
N= 100  
ODN :45 
LDN: 55 
 
ODN 
24:76 
51 (22-90) 
LDN  
51:49 
53 (20-74) 
1, 3 6 & 12 months SF-36: QoL 
VAS: perceived health status 
Lumsdaine et al (2005) Good ODN 40 38:62 
49 (24-71) 
6 weeks & 12 months WHOQOL: QoL 
Minnee et al 
(unpublished) 
N/A - - - 1& 3 months SF 36: QoL 
 
Minz et al (2005) Moderate NR 75 28:72 
42 (11.6) 
3 months Modified BDI 
Spielbergers’ state and trait anxiety 
questionnaire 
Purpose made questionnaire measuring 
donors’ perception of physical and 
emotional recovery from surgery.  
Simmons et al (1977) Moderate NR 128 NR 5 days (n=128) 
1 year  (n=111) 
Purpose made happiness and self-esteem 
scales constructed from validated 
questionnaires.  
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Study Quality 
rating 
Type of 
nephrectomy 
No. included in 
analysis reported 
Demographics 
Gender (%M:F) 
Mean age 
(sd/range) 
Follow-up period Assessment: variable assessed 
Simmons et al (1982) Moderate NR 135 NR 3 weeks, 1 & 5-9 years  Rosenberg Self Esteem Scale 
Smith et al (2004) Good ODN  
LDN 
N= 48 
ODN: 41 
LDN: 7 
46:54 
48.7 (11.9) 
4 & 12 months PHQ: psychiatric diagnosis 
SF-36: QoL 
Taghavi et al (2001) Moderate NR 40 72:28 
22 (18-40) 
1 &3 months SCL-90: psychiatric diagnosis 
Varma et al (1992) Good NR 31 68:32 
46.2 (15.7) 
1 week PEN inventory: personality 
MHQ: psychological distress 
DAQ: psychological functioning 
 
Virzi et al (2007) Moderate ODN 48 21:79 
54.2 (33-81) 
6 months MMSE: psychiatric diagnosis 
HADS: depression and anxiety 
Self rated anxiety 
SF-36: QoL 
Walton-Moss et al (2007) Moderate LDN 15 
 
33:67 
46 (11.8) 
3&6months SF-36: QoL 
Yoo et al (1996) Poor NR 25 NR 1 month BDI: depression 
Hostility scale 
Death Anxiety scale 
Campbells’ Index of wellbeing: QoL 
ODN: open live donor nephrectomy  LDN: laparoscopic live donor nephrectomy  NR: not reported MMSE: mini mental state exam 
 QoL: quality of life    WHOQOL: world health organisation quality of life questionnaire.   VAS: visual analogue scale  
PHQ: patient health questionnaire  PRS: post operative recovery scale.   DAQ: dysfunctional analysis questionnaire  
MHQ: Middlesex Hospital Questionnaire   
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Table 3: SF-36 Mental Health Component Summary Score 
Postoperative period (months) Study Preoperative  
 1 4 12 
p-value Effect size 
 
Smith et al (2004) 54.7 (6.0)  50.9 (8.6) 51.5 (9.1) 4 months: 0.002 
12 months: 0.02 
4 months: -0.63 
12 months: -0.53 
Bergman et al (2005) 53.3 (9.2) 54.6 (8.8)   0.2 0.14 
All results reported are means (standard deviation)  
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Table 4: SF-36 Vitality domain score.  
 Postoperative period (months) Study Preoperative  
1 3 6  12 
p-value Effect size 
 
Clinically 
significant 
 
Lombotomy incision 
87.0 (12.1) 
 77.8 (19.9) 85.8 (12.8) 
 
- -  0.002 
 
1 month: -0.8 
3months: -0.1 
 
1 month: min. 
3 months: no 
Aguiar et al (2007) 
Subcostal incision  
82.7 (13.8) 
75.0 (17.5) 85.3 (13.9) - -  0.002 1 month:-0.6 
3months: 0.19 
1 month: min 
3 months: no 
Younger donors 
83.6 (16.5) 
 78.1 (20.4) 82.6 (17.9)   3months:-0.3 
6months:-0.06 
3months:min. 
6months:no 
Minnee et al (unpublished) 
Older donors  
(≥55 years) 
87.9 (13.8) 
 78.1(19.5) 80.3 (20.3)   3 months: -0.7 
6 months: -0.55 
3 months: min 
6months: min 
Smith et al (2004) 77.6 (12.6) - -  68.9 (19.4) 0.001 -0.69 Min 
Walton-Moss et al (2007) 73.9  42.1 58.2  NR - 3 months: mod. 
6 months: mod 
Bergman et al (2005)* 80 (65-85) 60 (40-85)    0.003   
Virzi et al (2007) 56.7 (14.8)   55.7 (16.6)  0.7 -0.07 No 
ODN 
80 
 
63 
 
72 
 
70  
 
80 
1 month: 0.02 
3 months: 0.02 
- - KOK ET AL (2006)1 
LDN 
78 
 
60 
 
74 
 
71 
 
76 
1 month: <0.002 
3months: 0.04 
  
ODN denotes open donor nephrectomy  LDN denotes laparoscopic donor nephrectomy *results presented as median (IQR) all other results reported are means (standard deviation)  
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Table 5: SF-36 Social functioning domain score.  
Postoperative period (months) Study Preoperative 
1 3 6 12 
p-value ES Clinically significant 
 
Lombotomy incision 
95.0(10.2) 
75.4 (24.5) 82.5(13.5)   <0.001 1month:-1.92 
3months:-1.2 
1month: mod 
3months: mod. 
Aguiar et al (2007) 
Subcostal incision  
 91.7 (17.5) 
 
81.7 (118.5) 
 
 84.8 (9.1) 
  <0.001 1month:-0.57 
3months:-0.4 
1month: mod. 
3months: min 
Smith et al (2004) 95.4(9.5)    89.9 (21.2) NS -0.58 Min. 
Walton-Moss et al 
(2007) 
99.1  66.1 80.4  NR NR 3 months: mod. 
6 months: mod. 
Bergman et al (2005) 100 (87.5-100) 87.5 (62.5-100)    0.03   
Virzi et al (2007) 52.7 (12.7)   57.7 (10.8)  0.06 0.39 Min. 
Younger donors 
89.6 (18.3) 
  
91.6 (15.9) 
 
95.3 (12.3) 
  3 month: 0.1 
6 month: 0.3 
3months: no 
6 months: min. 
Minnee et al 
(unpublished) 
Older donors 
(≥55years) 
96.1 (8.3) 
 87.5 (23) 86 (22.4)   3 month: -1.03 
6 month: -1.2  
3months: min. 
6 months: mod. 
ODN 
90 
70 
 
85 
 
90 
 
90 
 
1 month: <0.05 
3months: NS 
- - Kok et al (2006) 
LDN 
 92 
75 90 90 95 1 month: :0.002 
3months: NS 
- - 
ODN denotes open donor nephrectomy  LDN denotes laparoscopic donor nephrectomy *results presented as median (IQR) all other results reported are means (standard deviation)  
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Table 6: SF-36 Role Emotion domain score 
Postoperative period (months) Study Preoperative 
1 3 6 12 
p-value Effect Size Clinically 
significant 
 
Lombotomy 
access 
96.7 (10.2) 
86.8 (20.4) 87.5 (16.2)   0.015 1month:-0.97 
3months:-0.9 
1month:min 
3months:min 
Aguiar et al (2007) 
Subcostal access 
94.4 (15.4) 
90 (19.9) 85.7 (16.9)   0.015 1month:-0.29 
3months:-0.56 
1month:min. 
3months:min 
Smith et al (2004) 98.6 (6.7)    93.1 (22.87) NS -0.82 Min. 
Walton-Moss et al 
(2007) 
97.5  71.8 79.5  NR NR- 3 months: mod 
6 months: mod. 
Bergman et al (2005)* 100 (100-100) 100 (66.7-100)    0.007  
 
 
Younger donors 
91.4 (23) 
 88.5 (29.4) 92.8 (22.4)   3 month: 0.13 
6 month: 0.06 
3 month: no 
6 month: no 
Minnee et al 
(unpublished) 
Older donors  
(≥55 years) 
97.6 (8.7) 
  
81 (35.9) 
 
82.7 (37.4) 
  3 month: 1.9 
6 month: 1.7 
3 month: mod. 
6 month: mod. 
ODN 
92 
 
85 
 
 
90 
 
93 
 
98 
1 month: <0.05   
3months: NS 
- - Kok et al (2006) 
LDN 
90 
 
65 
 
92 
 
95 
 
95 
1 month:<0.002 
3months: NS 
  
ODN denotes open donor nephrectomy  LDN denotes laparoscopic donor nephrectomy *results presented as median (IQR) all other results reported are means (standard deviation)  
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Table 7: SF-36 Mental Health domain score 
Postoperative period (months) Study Preoperative 
1 3 6 12 
p-value Effect Size 
 
Clinically significant 
 
Lombotomy access 
85.2 (13.7) 
81.5(20.1) 91.0 (15.1)   0.035 1month:-0.27 
3 months:0.4 
1 month: no 
3 months: min 
Aguiar et al (2007) 
Subcostal access 
84.5 (12.4) 
79.1(20.1) 86.4 (16.7)   0.035 1month:-0.4 
3 months: 0.15 
1 month: min 
3 months: no 
Smith et al (2004) 82.6 (13.5)    78.4 (16.1) NS -0.31 No 
Walton-Moss et al 
(2007)* 
85.1  75.7 76.6   
NR 
 
NR 
3 months: min 
6 months: min 
Bergman et al(2005) 84 (72-88) 88 (76-96)    0.09  no 
Virzi et al (2007) 64.8 (13.4)   66.6 (17)  0.7 0.13 no 
Younger donor 
86.1 (11.3) 
 
90.9 (12.5) 
  
90.9 (12.4) 
  3 month: 0.4 
6 month: 0.4 
3 month: no 
6 month: no 
Minnee et al 
(unpublished) 
Older donor  
(≥55 years) 
 
88 (14.2) 
  
90 (14.7) 
 
86.5 (20) 
  3 month: 0.14 
6 month: -0.1 
3 month: no 
6 month: no 
ODN 
70 
65 
 
65 
 
73 
 
68 
 
1 month: <0.05   
3months: NS 
- - Kok et al (2006) 
LDN 
68 
62 63 65 65 1 month:<0.002 
3months: NS 
  
ODN denotes open donor nephrectomy  LDN denotes laparoscopic donor nephrectomy *results presented as median (IQR) all other results reported are means (standard deviation)  
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Table 8: Quality of life following live kidney donation 
Study Instrument Preoperatively Postoperatively Effect size/p-value 
Psychological 
16.7 (16.0-8.0) 
6 weeks:16.0 (14.7-6.7) 
12months: 16.0 (14.0-7.2) 
 
Social 
17.3 (9.3-0) 
6 weeks: 17.3 (10.6-0.0) 
12months: 17.3 (6.7-0.0) 
 
Lumsdaine et al (2005)  WHOQoL 
Environmental 
17.0 (12-0) 
6 weeks: 16.5 (9.00-0.0) 
12months: 16.0 (11.0-0.0) 
 
Minz et al (2005)* Perceived Social Support 
Questionnaire 
58 (54-62) 3months: 60 (58-64) p=0.000. 
Yoo et al (1996) Campbell’s index of wellbeing 39.23 39.43 p=-0.06 
* results presented as median (IQR), all other results presented as mean (sd)
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Table 9: Prevalence of psychological symptoms in live kidney donors.  
Study Instrument Preoperative period Postoperative period  Results 
Middlesex 
Hospital 
Questionnaire 
Free floating anxiety: 1.68 
obsession:2.74 
phobic anxiety:1.83 
somatic anxiety:1.61 
depression traits:2.58 
hysteria traits:1.32 
Free floating anxiety: 1.9 
obsession: 3.55 
phobic anxiety:2.06 
somatic anxiety:3.23 
depression traits:2.32 
hysteria traits:1.45 
The preop. scores were within normal range and this did not change 
postop.  with the exception of somatisation which increased significantly 
(p<0.001).  
 
Varma (1992) 
PEN inventory Psychoticism:2.26 
Extraversion:10.45 
Neuroticism:3.10 
L:10.03 
Psychoticism:1.94 
Extraversion:10.32 
Neuroticism:3.97 
L:9.52 
Preop. scores were within normal range indicating emotional stability. 
Postop. Scores were not significantly different in any donors 
Modified BDI Mean score: 0 (0-1) 
Prevalence of mild 
depression: 0 
Prevalence of major 
depression: 0 
Mean score: 0 (0-2) 
Prevalence of  mild 
depression: 4 
Prevalence of major 
depression: 0 
Statistically significant increase in scores of the modified BDI (p=0.046). 
Increase in BDI score due to new cases of depression alone.   
Minz et al 
(2005)* 
Spielberger State 
and Trait anxiety 
questionnaire 
 
Anxiety Trait:32 (28-36) 
Anxiety State: 31 (26-34) 
 
Anxiety Trait: 27 (24-31) 
Anxiety State: 24 (22-30) 
Anxiety trait scores were significantly lower postop. (p=0.001) but 
remained within the normal range (25-42) 
Anxiety state scores were significantly lower postop. (p<0.001)  and 
postoperatively  were not within the normal range (31-43) 
BDI Mean: 7.8 Mean: 7.83 No significant difference in mean BDI scores  
Hostility scale 
from SCL-90-R 
8.14 9.97 Statistically significant  increase (p<0.05) 
Yoo et al 
(1996) 
Death anxiety 20.38 23.00 Statistically significant increase in anxiety concerning dying 
Hamilton Rating 
Scale for 
Depression 
5.8 (3.4) 
Score>7: 37.5% 
6.5 (5.3) 
Score>7: 33.3% 
Non significant  (p=0.4) increase in scores  
Hamilton 
Anxiety Scale 
8.9 (5.5) 
Score>18: 12.6% 
8.9 (5.7) 
Score>18: 0% 
Non significant  (p=0.9) increase in scores 
Virzi et al 
(2007) 
Self-Rating 
Anxiety Scale  
28.2 (5.2) 28 (5.1) Non significant  in scores (p=0.8) 
* results presented as median (IQR), all other results presented as mean (sd)
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Study Instrument Preoperative period Postoperative period  Results 
Smith et al 
(2004) 
DSM-IV criteria 
assessed using 
data from patient 
health 
questionnaire, 
clinical 
interview and 
casenote review. 
Cases: 1;Depressive 
disorder, dysthymia 
 
Point prevalence: 2% 
4 months 
Cases: 12; adjustment 
disorder (8); anxiety 
disorder (3); depressive 
disorder dysthymia (1)  
Point prevalence: 25% 
Incidence: 23% 
12 months 
Cases:7; adjustment 
disorder (1); anxiety 
disorder (1); depressive 
disorder (5, major 
depression n=3, dysthymia 
n=2) 
Point prevalence: 15% 
Incidence: 13%	  
12-month prevalence 31% postoperatively compared with 10% 
preoperatively. 12 month incidence of 29%. Five (71%) of the cases at 
12 month postoperative were cases at 4month postoperative.  
Taghavi et al 
(2001) 
SCL-90 All scores within the 
normal range. No cases  
Depression: 7 (5 
codiagnosed) 
Anxiety: 6 (5 codiagnosed) 
Obsession: 9 (6 
codiagnosed) 
Conversion: 1 
Phobia: 0  
Significant changes found in 13 cases. No difference between 1- and 3-
month follow-up.  
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ABSTRACT  
Background 
Individuals with end-stage kidney disease need dialysis or a kidney transplant. Kidney 
transplantation from a living donor is the preferred treatment. Live kidney donor 
transplantation, however, is an invasive surgery performed on a healthy individual for the 
benefit of another person. Therefore, donors should be fully informed of the risks involved in 
donation. The medical outcomes for kidney donors are well known, however, the research 
investigating the psychosocial impact of donation is limited. Understanding the psychosocial 
outcome of living kidney donation would promote informed consent, allow donors to plan 
their postoperative recovery period, and guide the development of services that maintain the 
long-term health of donors. 
Aims 
This study aimed to investigate the postoperative quality of life of live kidney donors, to 
investigate which variables predict postoperative psychosocial outcome, with particular 
interest in the variable of coping style and to gather information regarding how individuals 
decide to become living kidney donors and how satisfied they are with their pre- and post-
operative care. 
Methods 
Living kidney donors at Glasgow Western Infirmary, Manchester Royal Infirmary and St. 
James’ Hospital, Leeds were asked to complete a preoperative assessment consisting of the 
SF-36, HADS, COPE and The Donor Decision Control Scale. Four weeks postoperative, 
donors were asked to again complete these questionnaires, and in addition The Living Donor 
Survey.  
Results 
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Complete data was available for thirteen donors. The results indicate that live kidney 
donation had a significant adverse affect on the physical wellbeing of the donors; the 
postoperative scores on the PCS and all of the corresponding domains were significantly 
lower and with a large effect size. Five (38%) of the donors experienced postoperative 
complications, three of whom were readmitted to hospital. With respect to psychological 
wellbeing, donors’ scores on the MCS did not differ significantly from their preoperative 
scores. With respect to anxiety, for the group as a whole, postoperative HADS anxiety scores 
were lower and the severity and prevalence of anxiety symptoms reduced. For depression 
there was only a marginal increase in HADS depression scores.  Analysis of each individual’s 
outcomes indicated that there was a marked difference in the impact of donation. The results 
suggest that poor psychosocial outcome following donation was marginally associated with 
relying on mental disengagement as a coping strategy. Improved outcome in the 
postoperative period was associated with seeking social support 
Conclusions 
The physical health of donors is adversely affected by live kidney donation. Four weeks 
postoperatively live kidney donors report their physical health as being worse than those with 
long-standing illness. The psychological wellbeing of the majority of donors appears to be 
largely unaffected by live kidney donation. However, a minority of donors report a poorer 
psychological wellbeing following donation. Individuals who use active coping strategies 
have higher postoperative MCS scores, reflecting better psychological wellbeing. However, 
this conclusion should be interpreted with caution due the small sample size and therefore the 
possibility of a type I error.  
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1. INTRODUCTION 
End-stage kidney disease is the complete, or almost complete, failure of the kidneys to function. 
The kidneys can no longer remove waste, concentrate urine, and regulate many other important 
bodily functions. Patients who have reached this stage need dialysis or a kidney transplant. 
Kidney transplantation is preferred because of superior quality of life and survival rates. Live 
kidney donor transplantation provides a better outcome than a cadaveric donor5 transplantation. 
One year graft survival rates for live kidney donor transplantation range from 88.8% to 93.9% in 
comparison to 75.7% - 87.7% for cadaveric donor transplantation. Graft lifespan is also superior 
for living donor transplantation; a living donor graft had a life span of on average  21.6 years in 
comparison to 13.8 years for a cadaveric donor graft (Hariharan et al, 2000).  
 
The Human Tissue (Scotland) Act (2006) permitted donations from non-related donors and 
withdrew previous restrictions prohibiting individuals obtaining anything in return for donating 
and thus led to the introduction of new types of donor-recipient relationships (Table 1).  As a 
consequence of this act and increased awareness of the benefits of live donation, the number of 
live kidney donor transplants in the UK has increased across the years; there were 475 live 
kidney donor transplants in 2004-05, 589 in 2005-06, 690 in 2006-07, 831 in 2007-08, 927 in 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5 cadaveric donor transplant is a kidney transplant from a deceased donor.  
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2008-09 and 1,038 in 2009-10. Consequently live kidney donor transplants represent more than 
one in three of all kidney transplants (NHS blood and Transplant statistics).  
Insert Table 1 here 
 
Live kidney donor transplantation, however, is an invasive surgery performed on a healthy 
individual for the benefit of another person. Therefore, donors should be fully informed of the 
risks involved in donation. Furthermore, the effect of donation on the donor must be assessed to 
ensure that donation does not diminish the long-term psychological or physical health of the 
donor. Consequently, The Institute of Medicine and several transplant organisations including 
the American Society of Transplant Surgeons, The Division of Transplantation of the Health 
Resources and Services Administration, and the National Institutes of Health have suggested that 
further research into this area is needed in order to guide informed consent (Adams et al, 2002). 
Donors have also requested more information concerning outcomes; ten out of twenty donors 
interviewed by Walton-Moss et al (2007) reported that it would be beneficial to have more 
information concerning the postoperative recovery period such as the pace of recovery and 
amount of pain to expect. 
 
1.1 HEALTH RELATED QUALITY OF LIFE FOLLOWING LIVE KIDNEY 
DONATION 
Physical health 
The post-operative physical health of donors has been extensively investigated and it is now 
recognized that if a kidney is removed, the remaining kidney increases slightly in size and 
capacity and can carry on the function of the two. Kidney donors do not experience any long-
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term medical complications following donation; the life expectancy of donors is similar to that of 
non-donors and the risk of end stage renal failure does not increase (Ibrahim et al, 2009). The 
potential of having complications associated with the donation process is also low; the risk of 
death and serious surgical complications are 0.005% and 0.3% respectively (Nolan et al, 2004).  
The length of time to recover from live kidney donation varies from 2 - 12 weeks (NHS blood 
and Transplant website).  Recovery time will depend in part on whether the kidney is removed 
by an open incision (open donor nephrectomy), which involves a larger incision and therefore a 
longer recovery time estimated at eight weeks, or by laparoscopy (laparoscopic donor 
nephrectomy), which involves several small incisions and a shorter recovery time estimated at 
four weeks (NHS blood and Transplant website).  
 
Psychosocial Outcomes 
With respect to psychosocial outcomes, initially the available literature concluded that live 
kidney donors have a highly positive experience with kidney donation and an enhanced self-
esteem and self-regard related to this act.  This conclusion was drawn from several studies 
reporting that donors’ post-operative psychosocial outcome scores on the Medical Outcome 
Study 36-item Short Form Health Survey (SF-36) (Ware et al, 1994) indicated a higher or 
comparable quality of life to aged matched controls (Buell et al, 2005; Chen et al, 2004; 
Fehrman- Ekholm et al, 2000; Giessing et al, 2004; Johnson et al, 1999; Perry et al, 2003).  
However, more recently it has been argued that living kidney donors are a select sample of 
healthy individuals and therefore pre-donation SF-36 scores are higher than general population 
scores (Walton-Moss et al, 2007).  Thus it is possible that donation impacts negatively on 
donors’ psychosocial health yet their scores on health-related quality of life questionnaires will 
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remain comparable with population norms.  Therefore, in order to give an accurate description of 
the pace of recovery following donation and the psychosocial outcome of donation, a prospective 
study design is required. 
 
Within the renal transplant literature, the SF-36 is the most frequently used patient-reported 
measure of quality of life (Butt et al, 2008). The SF-36 assesses 4 components of mental health: 
(1) energy and fatigue (vitality domain) (2) limitations on social functioning because of physical 
or emotional problems (social functioning domain); (3) limitations on usual activities because of 
emotional problems (role-emotional domain) and (4) psychological distress and well-being 
(mental health domain). The results of the SF-36 can be expressed as domain scores with a value 
between 0 and 100, with greater scores representing better health, or as an overall representation 
of general mental health in the Mental Health Component Summary Scale (MCS). Seven  
prospective studies have measured the psychosocial outcomes for live kidney donors using the 
SF-36 (Aguiar et al, 2007; Bergman et al, 2005; Kok et al, 2006; Minnee et al, unpublished, 
Smith et al, 2004; Virzi et al, 2007; Walton-Moss et al 2007). Minnee et al (unpublished) 
represents an unpublished dataset obtained from the authors which supersedes the data published 
in Minnee et al (2008a and b). A summary of these studies is discussed here and the full data for 
each of the studies are presented in Tables 3-7 in the systematic review chapter.   
 
With respect to overall psychological wellbeing, the results from the MCS suggest that the 
majority of donors are not adversely affected by kidney donation. Bergman et al (2005) reported 
a non-significant improvement in the MCS score following donation; mean MCS score at 
baseline vs. mean MCS score 1-months postoperative: 53.3 (9.2) vs. 54.6 (8.8), p=0.2. Smith et 
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al (2004) found that donation was associated with a significant reduction in overall mental health 
with a moderate effect size four- and 12-months post-operative; mean MCS score at baseline vs. 
mean MCS score at 4-months and 12 months postoperative respectively: 54.7(6.0) vs. 50.9 (8.6), 
p=0.002 and 51.5(9.1), p=0.02. However, for only 19% of the sample was the decrease in the 
MCS scores at 12-months large and clinically and socially relevant, indicated by a change of ten 
or more points. Whereas, for 10% of the sample there was an improvement in psychosocial 
functioning that was better than would be expected for the group. 
 
With respect to the individual SF-36 domains, Bergman et al (2005) showed a significant decline 
in the domains of vitality, social functioning and role emotion one month post-transplant (Tables 
3, 4 and 5 respectively). Aguiar et al (2007) found that there was a significant decrease in all the 
SF-36 domain scores one month post-transplant, however this was partially recovered by three 
months posttransplant when scores were close to baseline (Tables 3 to 6). Similarly, Kok et al 
(2006) found that all SF-36 domain scores were significantly lower one month post-transplant 
but showed the start of recovery at three months post-transplant (Tables 3 to 6). Vitality, 
however, remained significantly lower three months post-transplant but had returned to pre-
transplant levels by six months post-transplant. The results were similar for both open donor 
nephrectomy (ODN)6 and laparoscopic donor nephrectomy (LDN)6 with the exception being that 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
6 LDN also referred to as key hole surgery involves removing the kidney through a smaller incision and performing 
the nephrectomy with the assistance of a telescopic lens. In comparison, ODN involves surgery completed manually 
and the incision is therefore larger.  
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for individuals undergoing LDN, role emotion was not significantly affected by donation. By 
comparison, Smith et al (2004) reported that one year post transplant, all SF-36 domain scores 
were lower  than the preoperative scores, indicating that live kidney donation adversely affects 
quality of life for a longer period than reported by the aforementioned studies. The difference 
between the preoperative scores and the one year follow-up scores was statistically significant 
only for the domain of vitality (p=0.001). However, the difference between the preoperative 
scores and the one-year follow scores for both social functioning and role emotion were 
clinically and socially relevant with moderately and large effect sizes respectively. Walton-Moss 
et al (2007) also found that, at three months post-transplant, all SF-36 domains scores were lower 
and that recovery began at six months post-transplant. However, scores remained lower than 
baseline and, with the exception of mental health, were moderately clinically and socially 
relevant (Tables 2 to 6). The results of  Minnee et al (unpublished)7 concur but only for older 
donors; vitality, social functioning and role emotion decreased three month post transplant and 
remained lower at six months post transplant with moderate to large effect sizes (Tables 3, 4 and 
5 respectively) . With respect to younger donors, however, six months post transplant, donors’ 
social functioning, role emotion and mental health domains surpassed pre-transplant scores 
(Tables 4, 5 and 6 respectively) and vitality was only slightly reduced. Virzi et al (2007) also 
reported positive effects of kidney donation in all domains, the exception being vitality which 
showed a marginal decrease (Tables 2 to 6). Bergman et al (2005) showed a non-significant 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
7 The author analysed older (≥ 55 years) and younger donors separately as the purpose of this study was to examine 
surgical outcome and the quality of life in older living donors.  
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(p=0.09) increase in the domain of mental health. Thus, in summary, for some individuals’ 
donation impacts negatively on their psychosocial functioning, but only for between three and 
six months after which quality of life begins to return to pre-transplant levels.  
 
The impact of kidney donation on the psychiatric morbidity of donors remains unclear.  Virzi et 
al (2007) reported a non-significant reduction in depression and anxiety scores as measured by 
the Hospital Anxiety and Depression Scale (HADS); baseline HADS scores vs. HADS scores 6-
month postoperative: anxiety 8.9 (5.5) vs.8.9 (5.7) p=0.9; depression 5.8 (3.4) vs. 6.5 (5.3) 
p=0.4. Whilst Minz et al (2005), reported a significant increase in depression scores as measured 
by a modified version of the Becks Depression Inventory (BDI); mean BDI scores at baseline vs.  
3-month postoperative score: 0 (0-1) vs.  0 (0-2); p=0.04.  Smith et al (2004) reported a striking 
increase in the point prevalence (2%-15%) and the twelve-month prevalence (10-31%) of 
psychiatric caseness between the preoperative period and the twelve-month postoperative period 
indicative of high incidence. The preoperative point prevalence for all of the disorders assessed 
was lower in the donors in comparison to the Australian population (2% vs. 11%) but the 12 
month point prevalence was higher (15%) in the donors. Specifically, for anxiety and depression, 
the twelve-month point prevalence for the Australian population was 12% which is lower than 
the twelve- month point prevalence for the donors (18%).  
 
Predictors of poor psychosocial outcomes.  
Understanding the factors that lead to poorer psychosocial outcome will inform the 
psychological screening of potential donors and postoperative follow-up.  Poor psychosocial 
outcome has been associated with the following: feelings of being abandoned after donation 
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(Brown & Sussman, 1982; Schover et al, 1997); poor recipient appreciation (Minz et al, 2005), 
unsuccessful transplantation (Fisher et al, 2005; Hivvas et al, 1980; Isotani et al, 2002 and 
Johnston et al, 1999) in particular recipient death (Minz et al, 2005 and Taghavi et al, 2001),  
persistent pain or prolonged hospitalisation in the donor (Minz et al, 2005) and previous 
preoperative psychiatric symptoms (Smith et al, 2004).  
 
It is proposed here that a further and hitherto neglected factor may be the way in which the donor 
copes with the aftermath of donation. There is extensive evidence to suggest a relationship 
between coping style and outcomes relative to physical and psychological health (Beutler et al, 
2003).  Avoidant coping with the medical complaint, and the physical and psychological distress 
it causes, has been linked to negative outcomes such as increased pain in migraine sufferers 
(Marlowe et al, 2003), poorer prognosis in cardiac patients (Kelsey & Leitten, 1996), increased 
relapse in psychiatric cohorts (Lemke & Moos, 2002 and 2003), increased risk of depression in 
the general population (Cronike & Moos, 1995), and poorer treatment outcome (Beutler et al, 
2003).  By contrast, active coping has been linked with better outcomes (LaMontagne et al, 
2004; Rosenberger et al, 2004).  The impact of coping style on psychosocial outcome following 
live kidney donation has not been investigated and thus is the focus of the present research. 
 
2. METHODOLOGY 
2.1 AIMS AND HYPOTHESES 
AIMS 
 To investigate the postoperative quality of life of live kidney donors.  
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 To investigate which variables predict postoperative psychosocial outcome, with 
particular interest in the variable of coping style.    
 To gather information regarding how individuals decide to become living kidney donors 
and how satisfied they are with their pre- and post-operative care. 
 
HYPOTHESES 
 The postoperative health-related quality of life of live kidney donors (as measured by the 
SF-36 and HADS) will not differ significantly from preoperative health-related quality of life. 
 Adaptive coping style will correlate positively with quality of life after donation as 
measured by the SF-36 and HADS.  
 
2.2 PLAN OF INVESTIGATION 
INCLUSION CRITERIA FOR PARTICIPANTS 
This study aimed to include:  
 Live kidney donors who underwent a nephrectomy8 at Manchester Royal Infirmary, 
Western Infirmary Glasgow and St. James University Hospital, Leeds between the period of 
January 2010 and October 2010 regardless of whether the kidney was then transplanted into the 
recipient or whether the transplant was successful. 
 Were fluent in written and spoken English 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
8 the removal of a kidney 
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 Were aged 18 years and above 
RECRUITMENT PROCEDURE 
Transplant coordinators are responsible for identifying a donor, providing support and education 
for the donor, all preoperative assessments, for organising organ and tissue retrieval, ensuring 
transplantation runs smoothly and undertaking a postoperative assessment.  Therefore, as they 
represent the hub of the transplant team and have the most frequent contact with the donor, 
recruitment took place via the transplant coordinator.  The recruitment procedure was as follows: 
 
 Transplant coordinators made patient information sheets available to all kidney donors 
who met the inclusion criteria for the present study. 
 Prior to nephrectomy, individuals who wished to participate signed a consent form and 
were given the donor questionnaire booklet 1 and a SAE for return to the principle researcher.   
 The principle researcher contacted the renal unit to obtain the date of transplantation.   
 Four weeks posttransplant the researcher mailed questionnaire booklet 2 and a SAE for 
return to the researcher.  
 Participants who did not return a booklet within two weeks of transplant were again sent 
booklet 2 and a letter outlining the importance of the study and requesting return of the 
questionnaires. 
 At the end of the study each participant and transplant coordinator were informed of the 
study’s findings.  
 
A four week follow-up was chosen for pragmatic reasons. The proposed three month follow-up 
(see appendix 4) was based on an extended period of data collection. However due to a delay in 
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obtaining Research and Development (R&D) approval for the study, the time available for data 
collection, given that the study was completed as part of the Doctorate in Clinical Psychology, 
was limited to six months.  A three month follow-up, would allow only three months for 
recruitment. Therefore to increase the participation rate, a shorter follow-up period was chosen.  
 
2.3 MEASURES 
Questionnaire booklet 1 (appendix 3) contained a patient information sheet, demographic form, 
consent form and the following questionnaires: 
 The Donor Decision Control Scale 
The Donor Decision Control Scale is a three-item 5-point Likert scale indicating the extent to 
which donors involve a family member(s) in their decision to donate.  Level one is a decision 
made independently by the donor; level two is a decision made by the donor after consulting 
with a family member(s); level three is a shared decision made by both the donor and a family 
member(s); level four is the donor relying on a family member(s) to make the decision after 
consulting with the donor; level five is the donor relying on a family member(s) to make the 
decision that the donor will donate.  The test-retest reliability for this scale in a prospective study 
of donor decision-making and outcomes was 0.76 (Walton-Moss et al, 2007). 
 
 The COPE 
The COPE is a 60-item self-report multidimensional coping inventory, which assesses the 
different ways in which individuals respond to stress.  The COPE was chosen as the means of 
measuring coping strategies over the more established Ways of Coping Questionnaire (WCQ) 
(Folkman & Lazarus, 1988) because the WCQ has a single factor for assessing active coping 
	   -­‐	  60	  -­‐	  
whereas the COPE has several separate scales for assessing different components of active 
coping. In this study the dispositional version of the COPE was used and participants were 
instructed to indicate the extent to which they use each response on a four-point Likert scale 
when they experience a stressful event. The full version of the COPE was used for the present 
study rather than the brief version of the COPE because the reliability coefficients for the brief 
version have all shown to only just exceed 0.50 (Carver, 1997) which is regarded as minimally 
acceptable (Nunally, 1978) whereas the reliability (internal consistency coefficients) for the full 
version is 0.62-0.92 (Carver et al, 1989).  
 
• Five subscales of the COPE measure problem-focused coping, where individuals actively 
try to alter the stressful situation.  These are as follows:  
Active coping: the process of taking steps to remove or circumvent the stressor or to ameliorate 
its effects. Active coping involves initiating direct action, increasing one’s efforts and trying to 
execute a coping effect in a stepwise fashion.  
Planning:  thinking about how to cope with the stressor. Planning involves producing action 
plans, thinking about what steps to take and how best to handle the problem.  
Suppression of competing activities:  putting other plans aside to concentrate on the problem. 
Restraint coping:  waiting until the appropriate time to act. This is an active coping strategy in 
the sense that the individual is focused on addressing the stressor but also a passive strategy in 
that they are using restraint and therefore not acting.  
Seeking support for instrumental reasons: seeking advice, assistance or information.  
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• Five subscales measure emotion-focused coping. This is where an individual’s actions are 
directed at regulating the emotional response to the stressor. The subscales of emotional-focused 
coping are as follows: 
Seeking emotional social support:  getting moral support, sympathy and understanding.  
Positive reinterpretation and growth:  focuses on managing the distress resulting from the 
stressor rather than managing the stressor itself. The value of this coping style is that it reduces 
distress but also intrinsically leads the individual to resume or continue problem-focused coping.  
Denial:  refusing to accept that a stressor exists or trying to act as though the stressor is not real. 
Acceptance:  the opposite of denial, therefore a functional coping response. The individual who 
accepts the reality of the situation is more likely to engage in attempts to address the stressors.  
Turning to religion: turning to religion in times of stress.  
 
• The following five subscales measure other less useful, coping responses: 
Focusing on and venting of emotions:  focusing on whatever distress or upset one is experiencing 
and venting those feelings. If the individual uses this time period to mourn and move, on this is a 
functional coping style. However, focusing on these emotions and prolonging this style of coping 
can impede adjustment and therefore be maladaptive.  
Behavioural disengagement:  akin to helplessness and is most likely to occur when the individual 
expects poor coping outcomes. It involves reducing one’s efforts to deal with the stressor and 
even giving up the attempt to attain goals with which the stressor is interfering. This again is an 
example of maladaptive emotional coping.  
Mental disengagement: This is where the individual tries to distract themselves from thinking 
about the  goals with which the stressor is interfering by using such tactics as immersing 
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themselves in TV or sleep, daydreaming or taking part in activities that compete with the 
stressor. 
Humour: coping by laughing at the situation or making jokes about it. 
Alcohol and drug use:  taking drugs or alcohol to improve mood or distract from the stressor.  
Validity and reliability: With respect to concurrent validity, the active coping and planning 
subscales on the COPE correlate significantly with scales of optimism, control, self-esteem, 
hardiness and Type A personality (r= 0.20 - 0.32) and active coping inversely correlates with 
trait anxiety (r= -0.25).  With respect to reliability, the internal consistency coefficients 
(cronbach’s alpha) are 0.62 - 0.92.  Test-retest reliability is between 0.42 and 0.77.  The 
correlation between the scale items is 0.02-0.69, which has been interpreted as indicating that the 
subscales are empirically distinct domains (Bowling, 2005; Carver et al, 1989).  
 
	  
 The Medical Outcomes Study 36-item Short Form Health Survey (SF-36)  
Within the renal transplant literature, the SF-36 is the most frequently used patient-reported 
measure of quality of life (Butt et al, 2008) because it contains eight of the most frequently 
measured health concepts (Bowling, 2005).  The only areas included in widely used health 
surveys which are not included in the SF-36 are sleep adequacy, cognitive functioning, sexual 
functioning, health distress, family functioning, self-esteem, eating, recreation/hobbies, 
communication and symptoms/problems specific to a diagnosis. However, the SF-36 correlates 
substantially with these omitted health concepts (r=0.4 or greater) and with the frequency and 
severity of many specific symptoms and problems (Ware et al, 1993 & 1994). The only known 
exception is sexual functioning which correlates weakly with the SF-36 scales.   
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Psychological wellbeing: the SF-36 assesses 4 components of mental health: (1) energy and 
fatigue (vitality domain) (2) limitations on social functioning because of physical or emotional 
problems (social functioning domain) (3) limitations on usual activities because of emotional 
problems (role-emotional domain) and (4) psychological distress and well-being (mental health 
domain).  
 
Physical wellbeing: the SF-36 assesses 4 components:  (1) physical functioning, (2) limitations 
on usual activities because of physical problems (role-physical domain), (3) bodily pain and (4) 
general health.   
 
Scoring and Interpreting results: Domain scores are expressed as a value between 0 and 100, 
with greater scores representing better health. Domain scores are interpreted using the following 
criteria: a difference of 5-points in any domain is considered minimally clinically and socially 
relevant and a difference of ten-points considered moderately clinically and socially relevant 
(Ware et al, 1994).  The Mental Health Component Summary Scale (MCS) and the Physical 
Health Component Summary Score (PCS) represent an overall view of mental and physical 
health respectively.   
Algorithms for the calculation of the PCS and MCS involve factor analysis of normative datasets 
gained from population norms which can be applied to all datasets throughout the world. 
Jenkinson (1999) found that when comparing the pre- and post-operative psychosocial outcomes 
of congestive heart failure patients, the calculated MCS, PCS and corresponding effect sizes 
were not significantly different depending on whether they used UK or US population norms. 
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Therefore, this study will calculate the MCS and PCS as advised in the SF-36 manual using US 
normative data.  
Reliability: The internal consistency reliability is 0.92 for the PCS and 0.89 for the MCS.  The 
test-retest reliability for an interval of two weeks is 0.89 for the PCS and 0.80 for the MCS 
(Ware et al, 1994) 
 
• Hospital Anxiety and Depression Scale (HADS) 
The HADS (Zigmond & Snaith, 1983) is a 14-item self-report measure designed to screen for the 
presence and severity of mood disorders in medically ill patients on a four-point Likert scale.  
The concurrent validity of the scale was tested by comparing the results of clinical assessment 
with the HADS scale results. This yielded significant correlations, 0.54 for anxiety and 0.79 for 
depression (Zigmond & Snaith, 1983).   
 
Questionnaire pack 2 (appendix 3) : four weeks post-operative, participants completed the SF-36 
and HADS again in order to compare health related quality of life after donation with pre-
operative health related quality of life.  In addition participants completed the following :   
 
 The Living Donor Survey  
The Living Donor Survey is a 60-item questionnaire designed to measure attitude toward living 
kidney donation, satisfaction with donation education, hospital care, care after discharge and 
health after surgery (Beavers et al, 2001).  In a study of donor decision-making and outcomes the 
internal consistency of the dimension that measured attitude to living donation was 0.75 using 
Cronbach’s alpha (Walton-Moss et al, 2007) 
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2.4 DESIGN 
Data Analysis 
A paired t-test compared donors’ pre- and post-operative SF-36 scores. Pre- and postoperative 
SF-36 scores were compared to population norms from The Oxford Healthy Living Survey 
(Jenkinson et al, 1993). SF-36 domain scores were interpreted using the following criteria: a 
difference of five points in any domain was considered minimally clinically and socially 
relevant, and a difference of ten points considered moderately clinically and socially relevant 
(Ware et al, 1994). The study by Smith et al (2003 & 2004) was the only prospective study of 
psychosocial outcomes of live kidney donors which calculated effect size and this study did so 
using Glass’ method (Glass & Hopkins, 2008).  To maintain consistency and allow comparison 
between publications, effects size was calculated using the same method whereby the effect size 
was calculated as mean at follow-up subtracted from the mean at baseline, divided by the 
standard deviation for the baseline. Effect sizes were classified as follows: 0.2-0.49 equated to a 
small difference, 0.5-0.79 equated to a moderate difference and 0.8 or above equated to a large 
difference (Cohen, 1988). 
 
With respect to the HADS, for the Anxiety and Depression scales, scores of between 8 and 10 
identified mild cases, 11-15 moderate cases and 16 or above, severe cases (Zigmond & Snaith, 
1983).   A paired t-test compared donors’ pre- and post-operative HADS scores. Changes in 
symptom severity and prevalence were also recorded. 
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Analysis of the relationship between coping strategy and psychosocial outcome involves 
multiple statistical comparisons. Multiple statistical comparisons increase the probability of 
making a Type I error. In order to reduce the chance of making a Type I error, a more 
conservative significance level of 0.01 will be applied this analysis.  
Statistical Power and sample size 
Aguiar et al (2007) measured the psychosocial outcomes for live kidney donors’ 1month 
postoperative using the SF-36.  The authors presented the results in accordance with surgical 
access, lombotomy or subcostal incision. The effect sizes calculated from the data in this paper 
and the sample size required to detect a statistically significant difference assuming the 
convention of α= 0.05 and power of 0.8 are presented in Table 2. 
 
Insert Table 2 here 
 
Aguiar et al (2007) did not present the MCS or the PCS scores. However, Bergman et al (2005) 
reported the MCS and PCS for 35 live kidney donors 4-weeks post-operative. The effect sizes 
calculated from this paper and the sample size required to detect a statistically significant 
difference assuming the convention of α= 0.05 and power of 0.8 are presented in Table 3. All 
donors in this study underwent laparoscopic nephrectomy.  
Insert Table 3 here 
 
Considering the data from each of these tables, it can be seen that with a sample of 20 
participants, the study had enough power to detect a statistically significant difference for all of 
the variables on the SF-36 presented in bold text.  For all the other variables recruitment would 
	   -­‐	  67	  -­‐	  
have needed to be extended beyond one year in order to obtain a participant rate high enough to 
detect a statistically significant difference. As this would be impractical for the present research 
study, which is carried out as part of the Doctorate in Clinical Psychology whereby recruitment 
should last over a period of six months, the aim was to obtain twenty complete datasets.  
Regardless of sample size and statistical power, the study was able to describe the number of 
individuals with a clinically and socially relevant change in SF-36 scores postoperatively and 
also the change in severity of anxiety and depression as determined by the HADS. 
 
3. RESULTS 
Recruitment and retention 
Figure 1 provides a flow chart of recruitment and retention. One hundred and eight living kidney 
donor transplants took place during the period of recruitment. MRI did not approach all living 
donors about the study due to appropriateness.  Twenty agreed to participate and returned 
baseline questionnaire pack. However, as all donors met the inclusion a criterion, the participant 
rate is estimated at 19%.  
Four participants erroneously completed their baseline questionnaires post-transplant, and 
therefore their HADS and SF-36 questionnaires were unusable9. Follow-up questionnaires were 
sent to all twenty participants. Individuals who returned a baseline questionnaire pack that could 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
9 The baseline SF-36 and HADS questionnaires must be completed before transplant to enable comparison between 
the preoperative health related quality of life and quality of life four weeks after transplant.  
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not be used were still sent the follow-up questionnaire pack in order to obtain a completed Living 
Donor Survey.  Fourteen participants returned the follow-up questionnaire pack.  
With respect to analysis, as can be seen from Figure 1, complete data were available for thirteen 
participants and therefore analysis was based only on these individuals. 
The demographic data for the final sample are represented in Table 4. The majority (11 out of 
13) of the donors were biologically related to the recipient. Eleven of the donors were in 
employment; two in part-time and nine in fulltime employment. The sample was predominately 
male, white British and married. No information was available on those who declined to 
participate in the study or were lost to follow-up due to restrictions in ethics approval.  
 
The follow-up questionnaires were mailed to all participants three weeks after donation and 
donors were asked to complete the questionnaires on the fourth week following donation. The 
dates on the questionnaires indicated that five donors completed the follow-up questionnaires 
four weeks postoperative and four donors completed the questionnaires five weeks postoperative. 
A reminder letter was sent to donors who had not returned follow up questionnaires by six weeks 
postoperative. Subsequent to this, three donors returned their questionnaires late; at seven, 
thirteen and fifteen weeks postoperative. The data for these donors are included in the analysis 
and acknowledged in the discussion chapter as a study limitation. The correlation between 
number of weeks to return follow-up questionnaires and postoperative outcome were as follows: 
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MCS r= -0.710, p=0.02; PCS r=0.66, p=0.85; HADS anxiety score r=0.8, p=0.001; HADS 
depression score r=0.8 p=0.001. This suggests that poorer psychosocial outcomes were 
associated with returning the follow up questionnaires late.  
Insert Table 4 here 
 
Donor decision-making 
The majority of participants (11 out of 13) reported involving someone else in their decision to 
donate a kidney. All eleven donors were either married or cohabiting and 10 out of the eleven 
involved their spouse or partner in their decision to donate a kidney. One married donor involved 
only their cousin in the decision-making process.  The majority (7 out of 13) of donors believed 
that they made their decision to donate independently. Four made the decision to donate after 
considering others’ opinions and two shared the responsibility for the decision with family or 
friends. No donor believed that the decision to donate was made by someone else. Individuals 
who involved another person in their decision to donate were asked to indicate how supportive 
this person was of their decision to donate on a ten-point Likert scale ranging from “not at all 
supportive” (scored 1) to “very supportive” (scored 10). Ten of the eleven donors who involved 
someone in their decision to donate reported that this person was supportive whilst one 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
10 Higher MCS and PCS scores indicated better psychosocial outcome whilst higher HADS scores indicate more 
symptoms of  anxiety and depression.  
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individual reported that this person was “not at all supportive” (mean score = 8.5 standard 
deviation 2.6; ten donors scored this questions as eight or above). 
 
Donors were asked in The Living Donor Survey if at any time they felt pressurised to donate. 
Only one donor responded positively to this question and reported that they had felt pressurised 
by the transplant team, the recipient and family and friends (Table 5 ).   However this donor 
responded strongly agree to the question “knowing what I know now, I would donate again.”  
 
Insert Table 5 here 
 
Donors’ satisfaction with donation education  
The key findings from the Living Donor Survey are presented in Table 6. The majority of donors 
reported that the process of donation, possible complications including risk of death, and the 
recovery process had been explained to them clearly. Furthermore all of the donors reported that 
any questions they had with respect to donation were answered by the renal team before surgery. 
All but one donor reported that the renal team addressed any complaints or needs that they 
expressed whilst in hospital or after discharge.  Possibly as a consequence of the clarity of 
information that donors received, the majority of donors reported that the amount of pain 
following surgery (11 out of 13), the length of their hospital stay (13 out of 13) and recovery 
time (7 out of 13) was consistent with or less than expected.  
 
Insert Table 6 here 
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Health related quality of life 
The mean length of hospital stay was 6.2 days, standard deviation 1.8, and ranged from 5 days to 
11 days. Five donors reported experiencing postoperative complications; 1 had blistering from 
their wound dressing lasting three weeks, 1 had blood in their urine for three weeks, 1 
experienced a chylothorax11 and breathing difficulties lasting three days, 1 had subcapusalar 
splenic hematoma12 which resulted in a spleenectomy and 1 had a wound infection and a urine 
infection lasting two weeks. The latter three of these individuals were readmitted to hospital 
following discharge for complications associated with the donation process.  Therefore the 
postoperative complication rate reported in this study was higher than that previously reported;  
Nolan et al (2004) reported that the postoperative complication rate was 0.3% whilst Ibrahim et 
al (2009) concluded that kidney donors have a health status similar to that of the general 
population following donation.  
 
Preoperative and postoperative scores on the SF-36 are presented in Table 7. Following 
donation, donors as a whole presented with significant reductions in the Physical Component 
Summary scale (PCS) and all the corresponding domains with the exception of the general health 
domain. For the general health domain, the p-value was 0.06 and therefore close to statistical 
significance. Given the small sample size in this study this result should be considered worthy of 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
11 chylothorax (or chyle leak) is where excess fluid accumulates  in the pleural cavity of the lungs 
12 bleeding from the spleen usually resulting in the removal of the spleen (spleenectomy) 
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further investigation. With respect to the effect size, for the PCS and all of the corresponding 
domains the decline was large (-0.82 to 2.22).  
 
Table 7 also details the number of individuals who have postoperative SF-36 domain scores that 
are defined as clinically and socially relevant, whether they are mildly or moderately clinically 
and socially relevant and whether the postoperative scores reflect an improvement or a decline in 
functioning 13.  As can be seen from Table 7, for the majority of donors the decline in physical 
functioning, as measured by the SF-36 PCS and the corresponding domains, was moderately 
clinically and socially relevant.  
 
With respect to the Mental Health Component Summary scale (MCS) and the corresponding 
domains, the only significant decrease for the group as a whole was seen in the vitality domain; 
donors reported significantly less energy and more fatigue following donation with a large effect 
size. For ten of the donors the decline in vitality was moderately clinically and socially relevant. 
Although mean postoperative scores for the domains of social functioning, role-emotion and 
mental health did not differ significantly from the mean preoperative scores, analysis of the 
individual scores for each donor indicates that for many there was a clinically and socially 
relevant decline in these domains following donation (Table 7).  
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
13 a difference of 5-points in any domain is considered minimally clinically and socially significant and a difference 
of ten-points considered moderately clinically and socially significant (Ware et al, 2003) 
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The postoperative MCS correlated positively with the postoperative PCS; correlation coefficient 
= 0.37, p=0.22. This suggests that as donors physical health improves so did their psychological 
wellbeing, and conversely, as their physical health deteriorated so did their psychological 
wellbeing. Likewise as the donors’ mental health deteriorated they reported lower physical 
functioning. It is important to note however that this correlation is not statistically significant.  
There were eight donors within the sample who reported clinically and socially relevant 
improvements in health-related quality of life following donation. Table 8 outlines in which 
domain improvements were reported. Each of these donors donated to a family member and 
therefore it is possible that the scores improved after donation due to the improvement in the 
recipients’ health and the consequential reduction in worry or caring duties in the donor. Support 
for this hypothesis comes from the fact that seven donors reported clinically and socially relevant 
reduction in psychological distress (mental health domain) following donation whereas only 
three reported an increase. Furthermore before donation, donors reported that their social 
functioning was lower than that of the UK population indicating that emotional distress was 
responsible for them spending less time in social activities (Table 7).  
 
Insert Table 7 and 8 here 
 
A score of 42 or less on the MCS is indicative of a diagnosis of depression. (Ware et al, 1994). 
Preoperatively three donors had a MCS score below 42, only one of these individuals, however, 
continued to have a score below 42 following donation. However, postoperatively, four new 
donors fell below the cut off point for psychiatric caseness. Within this study psychiatric 
diagnosis, in particular a diagnosis of anxiety and depression was detected by the HADS. 
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Postoperative anxiety scores were lower than preoperative anxiety scores, but this result failed to 
reach statistical significance (mean anxiety score: preoperative vs. postoperative= 6.4, sd 4.4 vs 
4.8, 4.2, t=1.33 p=0.2). Five donors were categorised as anxiety cases before donation. 
Following donation, two of these donors were no longer cases and the severity of anxiety in two 
of these donors decreased. There were two new cases of anxiety following donation; two donors 
did not reach anxiety caseness on the HADS before transplant but met the HADS criteria for 
mild anxiety following donation.  
With respect to depression, for the group as a whole, scores on the HADS depression inventory 
increased following donation (mean depression score: preoperative vs. postoperative= 2.7, sd 3.3 
vs 3.9, 4.4, t=1.1 p=0.3). Again this result failed to reach statistical significance. Before donation 
only one donor met the HADS criteria for depression. Following donation this donor continued 
to meet the HADS criteria for moderate depression and two new donors met the criteria for mild 
depression.  
Factors associated with postoperative psychosocial outcomes  
Pre-operative SF-36 scores and post-operative health-related quality of life 
The results presented in Table 9 indicate that postoperative psychosocial outcome as measured 
by the SF-36 is not significantly correlated with pre-operative scores on the SF-36 or the HADS.  
 
Donor decision-making and post-operative health-related quality of life  
As none of the donors in the study relied on another to make their decision to donate it is not 
possible to assess the impact of the decision-making process on psychosocial outcome. However, 
as shown in Table 11, increasing feelings of pressure to donate did not correlate with 
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psychosocial outcome. Therefore it may be hypothesised that relying on others to make the 
decision to donate will not lead to poorer psychosocial outcome.   
 
Coping and post-operative health-related quality of life.  
SF-36: Significant associations were found between coping strategies and post-operative MCS 
and PCS scores (Table 10).  
When the significance level was set at p≤ 0.05, active coping, planning and seeking instrumental 
support were significantly associated with higher MCS scores. Mental disengagement showed a 
trend association with lower MCS scores (p<0.1>0.05). PCS scores were also positively 
associated with planning and, marginally, with turning to religion and acceptance. There was 
also a marginal negative association between PCS and mental disengagement.  
However, when the significance level was set at p ≤ 0.01 to take into account the risk incurring a 
type I error due to multiple comparisons, only active coping was significantly associated with 
higher MCS scores.  
 
HADS: When the significance level was set at p≤ 0.05, post-operative anxiety was associated 
with seeking instrumental social support and, marginally, with active coping. In the case of post-
operative depression, there were marginal negative associations with active coping and seeking 
emotional support. However, when the significance level was set at p ≤ 0.01, none of the coping 
strategies investigated significantly correlated with post-operative HADS scores.  
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Coping and pre-operative health-related quality of life 
SF-36:  Significant associations were found between coping strategies and preoperative MCS 
and PCS scores. When the significance level was set at p≤0.05, active coping and humour were 
significantly associated with higher MCS scores. By comparison lower MCS scores were 
significantly associated with denial (Table 10). Lower PCS scores were also significantly 
associated with seeking instrumental social support and, marginally, with mental disengagement 
(Table 10).    However, when a more conservative significance level of p≤ 0.01 was adopted to 
reduce to chance of a type I error, only seeking instrumental social support was significantly 
associated with lower PCS scores.  
 
Insert Tables 9, 10 and 11 here 
 
4. DISCUSSION 
Donor’s health-related quality of life was the primary outcome measure of the current study. The 
results indicate that live kidney donation had a significant adverse affect on the physical 
wellbeing of the donors; the postoperative scores on the PCS and all of the corresponding 
domains were significantly lower and with a large effect size. To give perspective, postoperative 
scores on the PCS and all the corresponding physical health domains, with the exception of 
general health, were lower than the scores obtained by the Oxford Healthy Living Survey from a 
sample with long-standing illness (Jenkinson et al, 1993).  
 
Potentially as a consequence of increased body pain and decreased physical functioning, 
postoperatively, donors reported significantly more fatigue and less energy (vitality domain) and 
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a significant reduction in social functioning due to physical and emotional problems. This result 
is not surprising given that the donors had undergone major surgery. Furthermore, given that all 
but two donors donated to a direct family member, it is possible that the donors were unable to 
fully recuperate due to having to care for the recipient or having reduced practical support from 
other family members who may have been caring for the recipient. The fact that the majority 
donated to a family member may also explain why the majority of donors reported a clinically 
and socially relevant decline in usual activities as a consequence of emotional problems (role 
emotion domain) despite only three donors reporting a decline in their mental health 
postoperatively.  
 
With respect to psychological wellbeing, donors’ scores on the MCS did not differ significantly 
from their preoperative scores. With respect to anxiety, for the group as a whole postoperative 
HADS anxiety scores were lower and the severity and prevalence of anxiety symptoms reduced. 
This result should be interpreted with caution, as it is possible that preoperative anxiety scores in 
the donor do not represent baseline scores but rather are inflated due to concerns for the ill health 
of the recipient and may also reflect the donors’ anxiety over their impending surgery. For 
depression there was only a marginal increase in HADS depression scores.   
 
Analysis of each individual’s outcomes indicated that there was a marked difference in the 
impact of donation. Whilst the majority were not adversely affected by donation and, more 
specifically, for eight donors there was an improvement in psychological functioning (Table 8), 
for some individuals there was an emotional cost to kidney donation. Three donors reported a 
decline in mental health and there were two new cases each of anxiety and depression.  
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Identifying why some donors have a poorer outcome is essential to screening of potential donors. 
The results suggest that poor psychosocial outcome following donation was marginally 
associated with relying on mental disengagement as a coping strategy. However, improved 
outcome in the postoperative period was associated with seeking social support whereas this 
coping strategy was associated with poorer wellbeing in the preoperative period. One possible 
explanation for this may be that since the donors were donating to a family member, seeking 
sympathy and moral support was considered inappropriate by others during the preoperative 
period because they had not undergone any surgical procedure and, unlike the recipient, the 
donor was in good health. By comparison, after donation others may have been more amenable 
to offering understanding and sympathy due to the donor having undergone major surgery and 
with considerable pain and discomfort.  
 
4.1 Comparison with previous research 
The study confirms and extends the results of previous prospective studies. With respect to 
physical wellbeing, four prospective studies measured the physical health of donors four week 
after live kidney donation using the SF-36 (Aguiar et al, 2007; Bargman et al, 2006; Bergman et 
al, 2006; Kok et al, 2006). As in this study, Bergman et al (2005) reported that the postoperative 
PCS was significantly lower than the preoperative PCS with a large effect size (p=<0.0001, 
effect size -2.29). The results of Bargman et al (2006) further supported this finding; 
postoperative PCS was significantly lower than the preoperative PCS (p<0.05) with a large effect 
size (effect size: standard laparoscopic nephrectomy= -1.89, hand assisted laparoscopic 
nephrectomy = -1.96). With respect to the individual domain scores, as in this study, one month 
after donation the domain scores for physical functioning, role physical and bodily pain are 
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significantly lower than preoperative scores (Aguiar et al, 2007; Bergman et al, 2006 and Kok et 
al, 2006) with a large effect size (Aguiar et al, 2007). Aguiar et al (2207) also supported the 
finding of this study in that, for the majority of donors, the decline in these domains was 
clinically and socially relevant. The current study reported that one month after donation, donors 
reported a significant decline in their general health with a large effect size. Furthermore, for 
seven of those donors the decline was socially and clinically relevant. By comparison, Aguiar et 
al (2007) and Bergman et al (2006) found that the decline in general health was not statistically 
significant (p-value for Bergman et al, 2006= 0.7; p-value for Aguiar et al, 2007= 0.9).  
 
With respect to psychological wellbeing following donation, Smith et al (2004) found that in the 
main donors’ psychological health was not adversely affected by donation, hence supporting the 
present study. However, there was a subset of donors who either experienced a significant 
reduction in their MCS or reported improved psychological wellbeing following donation. 
Previous studies measuring psychosocial outcomes one month postoperatively have also found 
that the dimension of vitality and social functioning show greatest amount of change from the 
postoperative period (Aguiar et al, 2007; Bergman et al, 2005; Kok et al, 2006; see Tables 3 and 
4). In the current study, the postoperative decline in the dimension of role emotion failed to reach 
statistical significant despite five donors reporting that their decline was socially and clinically 
relevant. Again, this result is consistent with previous research; a statistically-significant decline 
in the dimension of role emotion was reported by Aguiar et al (2007), Bergman et al (2005) and 
Kok et al (2006). With respect to the dimension of mental health, the present study found that the 
majority of donors reported clinically and socially relevant improvement in this domain. 
Bergman et al (2005) and Minnee et al (unpublished) similarly found that mental health 
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improved following donation; however, Aguiar et al (2007) and Kok et al (2006) reported a 
significant reduction in this domain at one month postoperatively.   
Only two studies have evaluated the level of anxiety and depressive symptoms one month after 
live kidney donation (Taghavi et al,  2001; Yoo et al, 1996).  With respect to anxiety the result of 
this study is inconsistent with that of Taghavi et al (2001) who found that preoperatively all 
donors were within the normal range for anxiety symptomatology as measured by the  SCL-90, 
but, postoperatively, six donors met the criteria for anxiety disorder. Yoo et al (1996) reported 
that donors were significantly more anxious about death following donation. By comparison this 
study found that donors’ postoperative scores on the HADS indicated that they were less anxious 
and that prevalence of anxiety disorder decreased following donation. With respect to 
depression, the present study supports the finding by Taghavi et al (2001) that following 
donation the prevalence of depression amongst live kidney donors increased. By comparison, 
Yoo et al (1996) found that postoperative scores on the BDI were equivalent to preoperative 
scores.  
 
It has been argued that donors’ preoperative health-related quality of life scores will be higher 
than those of the general population, firstly, because they are a select sample of healthy 
individuals, and, secondly, because preoperatively they are encouraged to achieve a high level of 
fitness before donation. Several studies have reported population norms alongside preoperative 
SF-36 scores for their sample and found that, preoperatively, donors’ scores are higher for the 
MCS and PCS and all corresponding domains (Bergman et al, 2005; Smith et al, 2004 and 
Walton-Moss et al, 2007). The findings of this study, however, do not support these findings. 
When donors’ preoperative scores were compared with population norm scores reported in The 
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Oxford Healthy Living Survey (Jenkinson et al, 1993) only the dimension of role physical, 
bodily pain, general health, role emotion and vitality were higher than population norms. By 
comparison, the dimensions of physical functioning and social functioning were lower whilst 
mental health was comparable with population norms.  
4.2 Strengths and Limitations 
The main limitation of this study concerns the small sample size (n=13) which is considerably 
smaller than other prospective studies. In sixteen published studies, participation rates varied 
from 80% (Walton-Moss et al, 2007) to 100% (Aguiar et al, 2007; Minnee et al, 2008a)14. Whilst 
retention rates ranged from 100% four week postoperatively (Minnee et al, 2008a) to between  
82% (Lumsdaine et al, 2005) and 100% (Minnee et al, 2008) one-year postoperatively15.  It is 
possible however, that high retention and participation rates were obtained by previous 
researchers because assessments were carried out by the renal team and therefore donors were 
more willing to participate and questionnaires were part of the routine clinical assessment.  The 
present small sample introduces the possibility of a type II error. Furthermore, the small sample 
size prevents investigation of how the donor-recipient relationship may impact on the decision-
making process, satisfaction with donation and psychosocial outcome. On the positive side 
however, despite the small sample size the study showed several statistically significant results 
of importance, identified individuals who had a clinically and socially relevant change in 
psychosocial functioning, and, a change in prevalence of anxiety and depression symptoms.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
14 Walton-Moss et al (2007) n=52; Aguiar et al (2007) n= 60;  Minnee et al (2008) n=60 
15 Lumsdaine et al(2005) participation n=52 and retention n=40 
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Another limitation of the study involves selection bias. It is possible that donors with adverse 
outcomes were less willing or able to participate. The correlation between the number of weeks 
to return a questionnaire and the MCS and HADS score may support this hypothesis. 
Furthermore, Bergman et al (2005) noted that although donors who withdrew from the study 
postoperatively did not differ with respect to demographic and intraoperative data, they did have 
a lower postoperatively quality of life. Unfortunately, no other study reported on the outcome of 
those who refused to participate in the study or were lost to follow up despite this possibly being 
obtainable from medical record or follow up clinic reports. Therefore, this is an area that 
warrants further investigation.  
 
The validity of the HADS and SF-36 scores in the preoperative period require attention. It is 
possible that, pre-transplant, donors under-report psychological problems and difficulties in 
functioning due to the desire to become a donor. Whereas, following transplantation, the donors 
do not have to meet an inclusion criterion and therefore provide more reliable reports. With the 
exception of Smith et al (2004), the evaluation of functioning and psychiatric caseness has been 
assessed by self report. In Smith et al (2004) the current and past (last 12 months and lifetime) 
psychiatric caseness was established by a psychiatrist using information from a semi-structured 
interview combined with information from the self-completed patient-health questionnaire. 
Furthermore, donors and their family in this study were given an education session stressing the 
importance of mental wellbeing and the implication of hiding symptomatology, and were 
informed that the psychiatrist had access to medical records and interviews conducted over the 
preceding months. Smith et al (2004) indicated that live kidney donation has a negative impact 
on the quality of life for some donors which can last up to 12-months post transplant. 
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Furthermore, unlike others, this study reported a striking increase in point prevalence and 
incidence post transplant. Unfortunately, Smith et al (2004) did not report the accuracy of the 
self-completed assessment in comparison to the review of medical records and assessment by the 
psychiatrist. The present study may have overcome this bias to a certain extent, as the participant 
information sheet made it explicit that the research was independent of the renal team 
 
It can also be argued that the donors’ pre-operative level of functioning and anxiety and 
depression scores are not reflective of their “normal self” but rather reflect the functioning of (1) 
an individual who has a family member with end-stage renal disease facing a potentially 
unsuccessful transplant, and (2) an individual who in the near future will undergo major surgery. 
It is difficult to overcome this limitation as one cannot administer questionnaires before the 
recipient became unwell or before the donor decided to donate. Perhaps one way to overcome 
this problem is to compare post-operative scores to population norms; however as discussed 
before, this introduces other limitations (Walton-Moss et al, 2007).  
Finally, post-operative assessment was made only four weeks after donation therefore it remains 
unclear whether any adverse effects of donation are persistent.  
 
4.3 Conclusion 
The physical health of live kidney donors is adversely affected by live kidney donation. Four 
weeks postoperatively live kidney donors reports their physical health as worse than those with 
long-standing illness. However, this may be expected given that the donors were being asked to 
rate their physical health four weeks after undergoing major surgery. The psychological 
wellbeing of the majority of donors appears to be largely unaffected by live kidney donation. 
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However, there is a minority who pay an emotional cost. Nonetheless, all donors reported that in 
retrospect, they know now they would donate again and would recommend live kidney donation 
to others. 
The findings of this study suggest that the donor’s coping strategy influences psychosocial 
outcome, but the conclusion should be interpreted with caution due the small sample size and 
therefore the possibility of a type I error.  
 
4.4 Implications for development of renal services 
The majority of donors involved a family member in their decision to donate, thus highlighting 
the need for the renal team to involve family members in the evaluation and education sessions 
provided for the donor. There may be a case for developing educational materials for donors’ 
family members that highlight the factors to be considered in the decision making process and 
also guidance on how they can support the donor postoperatively 
 
The extent of psychological morbidity and level of anxiety and depression indentified in this 
study support the need for donors’ psychosocial outcomes to be to be monitored following 
transplant. Whilst, this study was unable to assess donors’ psychological wellbeing at various 
points throughout the post transplant period, the results of Smith et al (2004) would, however 
suggest that it would be essential to offer routine follow up appointment for 12 months for some 
donors. The SF-36 has been shown in this study to be an appropriate and useful tool for assessing 
post-operative psychological and physical wellbeing. Furthermore, donors appear to be willing to 
complete this questionnaire and, as Smith et al (2003) reported, donors find it a useful indicator 
of the issues that are important to them. Therefore, where it is not possible to offer all donors a 
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follow- up appointment by the renal team, donors could be screened for the suitability for referral 
to the clinical psychology service by mailing the SF-36 questionnaire at intervals throughout the 
post-transplant period.  
4.5 Future research 
A greater understanding of the impact of live kidney donation will be achieved from a larger, 
multi-centre prospective study which follows donors regularly over a prolonged period of time. 
Such a study should gather information about those who do not participate or are lost to follow-
up. To reduce bias, assessment should be carried out by an independent researcher. Such a study 
would facilitate identification of the risk factors for poor psychosocial outcome, support the 
screening of potential donors and clarify the role of Clinical Psychology with the transplant 
team.   
 
With respect to assessing donor satisfaction with donor education and donor decision-making 
process, individuals who do not proceed to donate for medical or personal reasons should also be 
included.  Particular attention should be paid to donor decision-making and satisfaction 
dependent on the donor- recipient relationship. For example, further research might consider 
those donors who donate altruistically or to a recipient with whom they do not have an emotional 
or biological relationship, to examine whether they involve a family member in the decision to 
donate, and have the same positive sense of self following donation.   
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Table 1: Donor-recipient relationships 
Definition Traditional 
compatible 
Incompatible Paired Altruistic 
Description Donor is blood 
group and tissue 
compatible with the 
recipient 
Donor may be 
blood group and/or  
tissue incompatible 
with the recipient, 
but with 
plasmapheresis* 
treatment 
transplantation my 
occur 
A blood group 
incompatible donor 
and recipient will 
be matched with 
another 
incompatible blood 
group donor and 
recipient, and the 
kidney will be 
exchanged between 
the two compatible 
pairs. 
A volunteer donates 
a kidney 
anonymously to an 
unknown recipient. 
Typical 
relationship 
Genetically related. Family, friend or 
anonymous donor 
Usually anonymous 
donor 
Anonymous donor 
*Plasmapheresis is the removal of antibodies that destroy organs from people with different blood types. These antibodies can rapidly destroy a transplanted kidney. 
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Table 2: Results of Aguiar et al (2007) 
 
SF-36 Effect size Sample req. to find a 
statistically significant result 
*Physical functioning L:-2.6 
S:-2.3 
L:3 
S:3 
*Role physical L:-1.3 
S:-1.7 
L:6 
S:4 
*Bodily pain L:-1.2 
S:-0.9 
L:6 
S:10 
General health L:0.1 
S:0.06 
L:620 
S:1719 
*Vitality L:-0.8 
S:-0.6 
L:12 
S:19 
*Social functioning L:-1.9 
S:-0.6 
L:4 
S:19 
Role emotion L:-0.97 
S:-0.3 
L:9 
S:71 
Mental health L:-0.3 
S:-0.4 
L:71 
S:41 
*SF-36 variables whereby a sample size of 20 will have sufficient power to detect a statistically significant 
difference. 
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Table 3: Results for Bergman et al (2005) 
 
SF-36 Effect size Sample req. to find a 
statistically significant result 
MCS 0.14 317 
*PCS -2.29 4 
* SF-36 variables whereby a sample size of 20 will have sufficient power to detect a statistically significant 
difference. 
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Figure 1: Flow chart of recruitment and retention 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recruited and returned baseline questionnaire pack: 20 
(Manchester Royal Infirmary 11; St James’ Hospital Leeds 4; Western 
Infirmary Glasgow 5) 
Baseline completed correctly: 16 
Baseline HADS and SF-36 questionnaires 
unusable: 4 
(Donor Decision Control Scale usable)  
Participants eligible for participation:108 
(Manchester Royal Infirmary 61; St. James’ Hospital Leeds 31; Western	  
Infirmary Glasgow 16)	  
Follow-up obtained: 1 
(Living	  Donor	  Survey	  usable)	  
No follow-up: 3 Follow-obtained: 
13 
No follow 
up: 3 
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Table 4: Demographic information for the sample included in the analysis.  
 
Number of subjects  13 
Referring hospital Manchester Royal Infirmary:8 
St. James’ Hospital, Leeds: 2 
Western Infirmary Glasgow: 3 
Weeks since transplant  
Mean (±SD) 
Range  
 
6.2 (3.7) 
4- 15 
Age at transplant (years) 
Mean (±SD) 
Range 
 
51.64 (7.70)  
39.0 -62.16 
Gender (male: female) 8:5 
Ethnic origin White British: 12 
Black- African:1 
Marital status Married: 11 
Cohabiting: 2 
Relationship with recipient Spouse: 2 
Son/daughter: 6 
Parent: 1 
Sibling: 1 
Other relative: 1 
Pooled donation: 1 
Altruistic donation: 1 
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Table 5: Donors decision making 
Aspect evaluated Response (n=13) 
Involved someone else in the decision to donate Yes: 11 
Person involved in decision to donate (n=11) Spouse/partner: 10 
Cousin: 1 
Decision making process Decision made independently: 7 
Decision made with consideration of others opinions; 4 
Decision jointly made with family and friends: 2 
I felt pressurised to donate by the transplant team  Disagree: 12  
Agree: 1 
I felt pressurised to donate by the recipient  Disagree: 12  
Agree: 1 
I felt pressurised to donate by family and friends  Disagree: 12  
Agree:1  
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Table 6: Donors’ satisfaction with information given by the renal team with respect to donation 
The information that I received about the surgery 
was 
Very clear: 10 
Moderately or somewhat clear: 2 
Somewhat vague: 1 
The information I received about the recovery 
process was 
Very clear: 5 
Moderately or somewhat clear: 5 
Moderately or somewhat vague: 3 
The information I received about possible 
complications of surgery was  
Very clear: 2 
Moderately clear: 11 
The information I received about the risk of death 
was 
Very clear: 11 
Moderately or somewhat clear: 1 
Moderately or somewhat vague: 1 
Before proceeding with surgery my questions were Completely answered: 11 
Moderately or somewhat answered: 2 
When I expressed needs or complaints in hospital 
these were 
Completely answered: 11 
Moderately or somewhat answered: 2 
When I expressed needs or complaints after 
discharge these were* 
Completely answered: 7 
Moderately or somewhat answered: 2 
Moderately or somewhat ignored: 1 
Amount of pain after surgery was Much more than expected: 1 
More than expected: 1 
As expected: 5 
Less than expected: 4 
Much less than expected: 2 
Length of hospital stay was As expected: 5 
Fewer days than expected: 5 
More days than expected: 3 
* 10 participants answered this question
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Table 7: Comparison of pre- and post-operative scores on the SF-36 and population norms from The Oxford Healthy Living Survey  
Scale Norms 
Mean ±SD 
Preoperative 
Mean ±SD 
Postoperative 
Mean ±SD 
Statistical Significance 
 
Effect size 
 
Clinically and socially 
relevant  
MCS - 49.08 (12.0) 43.07 (15.6) t=-1.27, p=0.229 -0.5 - 
PCS - 55.1 6 (7) 41.48 (7.1) t=5.05 p=0.000 -1.95 - 
Physical functioning 88.4 (17.9) 86.54 (18.64) 68.08 (16.01) t=3.18 p=0.008 -0.99 Mild improvement: 0 
Moderate improvement: 1 
Mild decline: 1 
Moderate decline: 9 
Role-physical 85.8 (29.9) 89.42 (21.7) 41.35(36.22) t=3.69 p=0.003 -2.22 Mild improvement: 0 
Moderate improvement: 1 
Mild decline: 0 
Moderate decline: 10 
Bodily pain 81.5 (21.6) 84.46 (26.11) 52.77 (6.82) t=2.80 p=0.016 -1.23 Mild improvement: 0 
Moderate improvement: 2 
Mild decline: 0 
Moderate decline:11 
General health 73.5 (19.9) 82.9 (8.87) 75.62 (13.85) t=2.06 p=0.06 -0.82 Mild improvement: 1 
Moderate improvement: 1 
Mild decline: 2 
Moderate decline: 5 
Vitality 61.1 (19.6) 69.7 (15.7) 46.6 (24.95) t=3.0, p=0.01 -1.47 Mild improvement: 0 
Moderate improvement:2 
Mild decline: 1 
Moderate decline: 10 
Social functioning 88.0 (19.5) 80.77 (27.77) 58.65 (33.22) t=1.63 p=0.13 -0.8 Mild improvement: 0 
Moderate improvement: 3 
Mild decline: 0 
Moderate decline: 9 
Role-emotion 82.9 (31.8) 87.18 (25.37) 69.23 (35.42) t=1.69 p=0.12 -0.71 Mild improvement: 0 
Moderate improvement: 2 
Mild decline: 0 
Moderate decline: 5 
Mental health 73.8 (17.2) 73.08 (21.46) 73.08 (20.06) t=0 p=1.0 0 Mild improvement: 3 
Moderate improvement: 4 
Mild decline: 1 
Moderate decline: 2 
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Table 8: Details of donors who experienced clinically and socially relevant improvements in health related quality of life following 
donation 
	  
Scale Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 Donor 6 Donor 7 Donor 8 
Physical functioning     Moderate    
Role-physical   Moderate       
Bodily pain   Moderate    Moderate    
General health     Mild  Moderate    
Vitality  Moderate Moderate       
Social functioning   Moderate   Moderate  Moderate    
Role-emotion  Moderate Moderate       
Mental health Moderate  Moderate Mild Moderate  Moderate  Mild  Mild  
Mild indicates a mild socially and clinically relevant improvement in SF-36 domain scores 
Moderate indicates a moderately socially and clinically relevant improvement in SF-36 domain scores 
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Table 9: Correlation between preoperative and postoperative scores on the HADS and SF-36.  
 
 Postoperative SF-36 scores Post operative HADS scores  
 MCS PCS Anxiety Depression 
Preoperative MCS r=0.25 
 p=0.4 
r=-0.43  
p=0.15 
r=-0.48  
p=0.13 
r=-0.2  
p=0.53 
Preoperative PCS r=-0.27  
p=0.37 
r=0.041 
 p=0.9 
r=0.2  
p=0.52 
r=0.3  
p=0.32 
Preoperative  HADS anxiety score r=-0.35  
p=0.25 
r=-0.03  
p=0.9 
r=0.49  
p=0.09 
r=0.26  
p=0.4 
Preoperative HADS depression score r=-0.43  
p=0.14 
r=0.16 
p=0.6 
r=0.55  
p=0.05 
r=0.5  
p=0.085 
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Table 10: Correlation between coping style and pre- and postoperative scores on the SF-36 and HADS 
 
 Preoperative SF-36 scores Postoperative SF-36 
scores 
preoperative HADS scores Post operative HADS scores  
 MCS PCS MCS PCS Anxiety Depression Anxiety Depression 
Active coping r=0.61  
p=0.04 
r=-0.9  
p=0.79 
r=0.7  
p=0.01 
r=0.23 
p=0.38 
r=0.54  
p=0.7 
r=-0.63  
p=0.03 
r=-0.56 
p=0.06 
r=-0.55  
p=0.06 
Planning r=0.05  
p=0.89 
r=0.09 
p=0.77 
r=0.63 
p=0.03 
r=0.59 
p=0.04 
r=-0.16 
p=0.63 
r=-0.3  
p=0.35 
r=-0.34 
p=0.27 
r=-0.41  
p=0.19 
Seeking 
instrumental social 
support 
r=0.32 
 p=0.31 
r=-0.68 
p=0.01 
r=0.67 
p=0.02 
r=0.21 
p=0.51 
r=-0.4  
p=0.2 
r=-0.47 
 p=0.13 
r=-0.61 
p=0.04 
r=-0.54  
p=0.72 
Seeking emotional 
support 
r=0.9  
p=0.79 
r=-0.48 
p=0.12 
r=0.48 
p=0.15 
r=-0.1 
p=0.75 
r=0.09  
p=0.79 
r=-0.14  
p=0.66 
r=-0.53 
p=0.79 
r=-0.51 
 p=0.09 
Suppression of 
competing activities 
r=0.46  
p=0.18 
r=-0.09 
p=0.78 
r=0.012 
p=0.97 
r=0.1 
p=0.77 
r=-0.42 
p=0.16 
r=-0.29 
 p=0.36 
r=0.21 
 p=0.52 
r=0.16  
p=0.61 
Turning to religion r=0.05  
p=0.87 
r=-0.22 
p=0.49 
r=0.5 
p=0.10 
r=0.51 
p=0.09 
r=-0.31 
p=0.33 
r=-0.17 
 p=0.60 
r=-0.34 
p=0.28  
r=-0.29 
 p=0.37 
Positive 
reinterpretation and 
growth 
r=33  
p=0.3 
r=-0.45 
p=0.14 
r=0.31 
p=0.33 
r=0.27 
p=0.39 
r=-0.39 
p=0.21 
r=-0.17  
p=0.60 
r=-0.11 
p=0.73 
r=-0.9  
p=0.78 
Restraint coping r=0.13 
 p=0.7 
r=-0.23 
 p=0.5 
r=0.22 
p=0.5 
r=0.19 
p=0.55 
r=-0.42  
p=0.9 
r=0.12 
 p=0.7 
r=-0.21 
p=0.51 
r=-0.19  
p=0.55 
Acceptance r=-0.24  
p=0.46 
r=0.8  
p=0.81 
r=0.3 
p=0.35 
r=0.56 
p=0.06 
r=0.93  
p=0.77 
r=0.19 
 p=0.56 
r=-0.29 
p=0.36 
r=-0.48 
 p=0.12 
Focus on and 
venting of emotions 
r=-0.25  
p=0.44 
r=-0.05 
p=0.90 
r=-0.35 
p=0.27 
r=-0.26 
p=0.41 
r=0.61  
p=0.37 
r=0.56  
p=0.06 
r=0.31 
 p=0.34 
r=0.44 
 p=0.15 
Denial r=-0.59  
p=0.04 
r=0.24 
p=0.44 
r=-0.35 
p=0.27 
r=0.7 
p=0.82 
r=0.7  
p=0.01 
r=0.89 
 p=0.00 
r=0.47  
p=0.13 
r=0.46  
p=0.13 
Mental 
disengagement 
r-0.2 
p=0.9 
r=-0.51 
p=0.09 
r=-0.56 
p=0.06 
r=-0.51 
p=0.09 
r=0.29 
p=0.36 
r=0.41 
p=0.19 
r=0.42 
p=0.17 
r=0.44  
p=0.15 
Behavioural 
disengagement 
r=-0.21  
p=0.52 
r=0.01 
 p=1.0 
r=-0.34 
p=0.29 
r=-0.28 
p=0.38 
r=0.37  
p=0.23 
r=0.56  
p=0.06 
r=0.13  
p=0.69 
r=0.35  
p=0.26 
Alcohol and drug 
use 
r=0.19  
p=0.57 
r=-0.46 
p=0.13 
r=0.02 
p=0.96 
r=-0.22 
p=0.49 
r=0.25  
p=0.94 
r=-0.16  
p=0.62 
r=0.88 
p=0.79 
r=-0.21 
p=0.51 
humour r=0.7 
p=0.02 
r=-0.11 
p=0.75 
r=0.06 
p=0.86 
r=-0.31 
p=0.4 
r=-0.62 
p=0.04 
r=-0.43 
p=0.19 
r=-0.59 
p=0.86 
r=0.45 
p=0.9 
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Table 11: Correlation between donor decision making and preoperative and postoperative scores on the HADS and SF-36 
 Preoperative SF-36 
scores 
Postoperative SF-36 
scores 
Preoperative HADS scores Post operative HADS 
scores  
 MCS PCS MCS PCS Anxiety Depression Anxiety Depression 
Pressure to donate by transplant 
team1 
r=0.22 
p=0.47 
r=0.19 
p=0.53 
r=0.16 
p=0.6 
r=0.13 
p=0.68 
r=-0.8  
p=0.79 
r=-0.56  
p=0.86 
r=0.007 
p=0.98 
r=-0.16  
p=0.59 
Pressure to donate by the recipient 
1 
r=0.15  
p=0.62 
r=0.19 
p=0.53 
r=0.23 
p=0.45 
r=0.16 
p=0.61 
r=-0.06 
p=0.84 
r=-0.09 
 p=0.76 
r=-0.13 
p=0.67 
r=-0.27 
 p=0.37 
Pressure to donate by friends and 
family1 
r=0.15  
p=0.52 
r=0.19 
p=0.53 
r=0.23 
p=0.45 
r=0.16 p=0.6 r=-0.06 
p=0.83 
r=-0.09  
p=0.76 
r=0.13  
p=0.67 
r=-0.27  
p=0.37 
Level of support from the 
individual involved in decision to 
donate2 
r=-0.18  
p=0.56 
r=-0.12 
p=0.69 
r=0.29 
p=0.34 
r=0.26 
p=0.38 
r=0.13 
 p=0.67 
r=0.005  
p=0.99 
r=-0.49 
p=0.09 
r=0.22  
p=0.47 
1scored on a 6point likert scores from strongly disagree to strongly agree       2scored on a 10 point likert scale from not at all supportive to very supportive 
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  and	  groups,	  to	  investigations	  of	  
the	  relationships	  between	  explicitly	  social	  and	  psychological	  levels	  of	  analysis.	  	  
The	  following	  types	  of	  paper	  are	  invited:	  	  
•	  Papers	  reporting	  original	  empirical	  investigations	  	  
•	  Theoretical	  papers,	  provided	  that	  these	  are	  sufficiently	  related	  to	  the	  empirical	  data	  	  
•	  Review	  articles	  which	  need	  not	  be	  exhaustive	  but	  which	  should	  give	  an	  interpretation	  of	  the	  state	  of	  the	  
research	  in	  a	  given	  field	  and,	  where	  appropriate,	  identify	  its	  clinical	  implications	  	  
•	  Brief	  reports	  and	  comments	  	  
1.	  Circulation	  	  
The	  circulation	  of	  the	  Journal	  is	  worldwide.	  Papers	  are	  invited	  and	  encouraged	  from	  authors	  throughout	  
the	  world.	  	  
2.	  Length	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Papers	  should	  normally	  be	  no	  more	  than	  5000	  words	  (excluding	  abstract,	  reference	  list,	  tables	  and	  
figures),	  although	  the	  Editor	  retains	  discretion	  to	  publish	  papers	  beyond	  this	  length	  in	  cases	  where	  the	  
clear	  and	  concise	  expression	  of	  the	  scientific	  content	  requires	  greater	  length.	  	  
3.	  Submission	  and	  reviewing	  	  
All	  manuscripts	  must	  be	  submitted	  via	  http://www.editorialmanager.com/bjcp/.	  The	  Journal	  operates	  a	  
policy	  of	  anonymous	  peer	  review.	  	  
4.	  Manuscript	  requirements	  	  
•	  Contributions	  must	  be	  typed	  in	  double	  spacing	  with	  wide	  margins.	  All	  sheets	  must	  be	  numbered.	  	  
•	  Tables	  should	  be	  typed	  in	  double	  spacing,	  each	  on	  a	  separate	  page	  with	  a	  self-­‐explanatory	  title.	  Tables	  
should	  be	  comprehensible	  without	  reference	  to	  the	  text.	  They	  should	  be	  placed	  at	  the	  end	  of	  the	  
manuscript	  with	  their	  approximate	  locations	  indicated	  in	  the	  text.	  	  
•	  Figures	  can	  be	  included	  at	  the	  end	  of	  the	  document	  or	  attached	  as	  separate	  files,	  carefully	  labelled	  in	  
initial	  capital/lower	  case	  lettering	  with	  symbols	  in	  a	  form	  consistent	  with	  text	  use.	  Unnecessary	  
background	  patterns,	  lines	  and	  shading	  should	  be	  avoided.	  Captions	  should	  be	  listed	  on	  a	  separate	  sheet.	  
The	  resolution	  of	  digital	  images	  must	  be	  at	  least	  300	  dpi.	  	  
•	  For	  articles	  containing	  original	  scientific	  research,	  a	  structured	  abstract	  of	  up	  to	  250	  words	  should	  be	  
included	  with	  the	  headings:	  Objectives,	  Design,	  Methods,	  Results,	  Conclusions.	  Review	  articles	  should	  use	  
these	  headings:	  Purpose,	  Methods,	  Results,	  Conclusions.	  Please	  see	  the	  document	  below	  for	  further	  
details:	  	  
http://www.bpsjournals.co.uk/document-­‐download-­‐area/document-­‐
download$.cfm?file_uuid=DE5A7349-­‐7E96-­‐C67F-­‐D27E88D8F6B03C99&ext=pdf	  
•	  For	  reference	  citations,	  please	  use	  APA	  style.	  Particular	  care	  should	  be	  taken	  to	  ensure	  that	  references	  
are	  accurate	  and	  complete.	  Give	  all	  journal	  titles	  in	  full.	  	  
•	  SI	  units	  must	  be	  used	  for	  all	  measurements,	  rounded	  off	  to	  practical	  values	  if	  appropriate,	  with	  the	  
imperial	  equivalent	  in	  parentheses.	  	  
•	  In	  normal	  circumstances,	  effect	  size	  should	  be	  incorporated.	  	  
•	  Authors	  are	  requested	  to	  avoid	  the	  use	  of	  sexist	  language.	  	  
•	  Authors	  are	  responsible	  for	  acquiring	  written	  permission	  to	  publish	  lengthy	  quotations,	  illustrations,	  etc.	  
for	  which	  they	  do	  not	  own	  copyright.	  For	  guidelines	  on	  editorial	  style,	  please	  consult	  the	  APA	  Publication	  
Manual	  published	  by	  the	  American	  Psychological	  Association.	  	  
5.	  Brief	  reports	  and	  comments	  	  
These	  allow	  publication	  of	  research	  studies	  and	  theoretical,	  critical	  or	  review	  comments	  with	  an	  essential	  
contribution	  to	  make.	  They	  should	  be	  limited	  to	  2000	  words,	  including	  references.	  The	  abstract	  should	  
not	  exceed	  120	  words	  and	  should	  be	  structured	  under	  these	  headings:	  Objective,	  Method,	  Results,	  
Conclusions.	  There	  should	  be	  no	  more	  than	  one	  table	  or	  figure,	  which	  should	  only	  be	  included	  if	  it	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conveys	  information	  more	  efficiently	  than	  the	  text.	  Title,	  author	  name	  and	  address	  are	  not	  included	  in	  the	  
word	  limit.	  	  
6.	  Supplementary	  data	  	  
Supplementary	  data	  too	  extensive	  for	  publication	  may	  be	  deposited	  with	  the	  British	  Library	  Document	  
Supply	  Centre.	  Such	  material	  includes	  numerical	  data,	  computer	  programs,	  fuller	  details	  of	  case	  studies	  
and	  experimental	  techniques.	  The	  material	  should	  be	  submitted	  to	  the	  Editor	  together	  with	  the	  article,	  
for	  simultaneous	  refereeing.	  	  
7.	  Copyright	  	  
Authors	  will	  be	  required	  to	  assign	  copyright	  to	  The	  British	  Psychological	  Society.	  Copyright	  assignment	  is	  a	  
condition	  of	  publication	  and	  papers	  will	  not	  be	  passed	  to	  the	  publisher	  for	  production	  unless	  copyright	  
has	  been	  assigned.	  To	  assist	  authors	  an	  appropriate	  copyright	  assignment	  form	  will	  be	  supplied	  by	  the	  
editorial	  office	  and	  is	  also	  available	  on	  the	  journal’s	  website	  at	  
http://www.blackwellpublishing.com/pdf/CTA_BPS.pdf.	  Government	  employees	  in	  both	  the	  US	  and	  the	  
UK	  need	  to	  complete	  the	  Author	  Warranty	  sections,	  although	  copyright	  in	  such	  cases	  does	  not	  need	  to	  be	  
assigned.	  	  
8.	  Colour	  illustrations	  	  
Colour	  illustrations	  can	  be	  accepted	  for	  publication	  online.	  These	  would	  be	  reproduced	  in	  greyscale	  in	  the	  
print	  version.	  If	  authors	  would	  like	  these	  figures	  to	  be	  reproduced	  in	  colour	  in	  print	  at	  their	  expense	  they	  
should	  request	  this	  by	  completing	  a	  Colour	  Work	  Agreement	  form	  upon	  acceptance	  of	  the	  paper.	  A	  copy	  
of	  the	  Colour	  Work	  Agreement	  form	  can	  be	  downloaded	  here.	  	  
9.	  Pre-­‐submission	  English-­‐language	  editing	  	  
Authors	  for	  whom	  English	  is	  a	  second	  language	  may	  choose	  to	  have	  their	  manuscript	  professionally	  edited	  
before	  submission	  to	  improve	  the	  English.	  A	  list	  of	  independent	  suppliers	  of	  editing	  services	  can	  be	  found	  
at	  http://authorservices.wiley.com/bauthor/english_language.asp.	  All	  services	  are	  paid	  for	  and	  arranged	  
by	  the	  author,	  and	  use	  of	  one	  of	  these	  services	  does	  not	  guarantee	  acceptance	  or	  preference	  for	  
publication.	  	  
10.	  Author	  Services	  	  
Author	  Services	  enables	  authors	  to	  track	  their	  article	  –	  once	  it	  has	  been	  accepted	  –	  through	  the	  
production	  process	  to	  publication	  online	  and	  in	  print.	  Authors	  can	  check	  the	  status	  of	  their	  articles	  online	  
and	  choose	  to	  receive	  automated	  e-­‐mails	  at	  key	  stages	  of	  production.	  The	  author	  will	  receive	  an	  e-­‐mail	  
with	  a	  unique	  link	  that	  enables	  them	  to	  register	  and	  have	  their	  article	  automatically	  added	  to	  the	  system.	  
Please	  ensure	  that	  a	  complete	  e-­‐mail	  address	  is	  provided	  when	  submitting	  the	  manuscript.	  Visit	  
http://authorservices.wiley.com/bauthor/	  for	  more	  details	  on	  online	  production	  tracking	  and	  for	  a	  wealth	  
of	  resources	  including	  FAQs	  and	  tips	  on	  article	  preparation,	  submission	  and	  more.	  	  
11.	  The	  Later	  Stages	  	  
The	  corresponding	  author	  will	  receive	  an	  email	  alert	  containing	  a	  link	  to	  a	  web	  site.	  A	  working	  e-­‐mail	  
address	  must	  therefore	  be	  provided	  for	  the	  corresponding	  author.	  The	  proof	  can	  be	  downloaded	  as	  a	  PDF	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(portable	  document	  format)	  file	  from	  this	  site.	  Acrobat	  Reader	  will	  be	  required	  in	  order	  to	  read	  this	  file.	  
This	  software	  can	  be	  downloaded	  (free	  of	  charge)	  from	  the	  following	  web	  site:	  
http://www.adobe.com/products/acrobat/readstep2.html.	  	  
This	  will	  enable	  the	  file	  to	  be	  opened,	  read	  on	  screen	  and	  annotated	  direct	  in	  the	  PDF.	  Corrections	  can	  
also	  be	  supplied	  by	  hard	  copy	  if	  preferred.	  Further	  instructions	  will	  be	  sent	  with	  the	  proof.	  Hard	  copy	  
proofs	  will	  be	  posted	  if	  no	  e-­‐mail	  address	  is	  available.	  Excessive	  changes	  made	  by	  the	  author	  in	  the	  proofs,	  
excluding	  typesetting	  errors,	  will	  be	  charged	  separately.	  	  
12.	  Supporting	  Information	  	  
BJC	  is	  happy	  to	  accept	  articles	  with	  supporting	  information	  supplied	  for	  online	  only	  publication.	  This	  may	  
include	  appendices,	  supplementary	  figures,	  sound	  files,	  videoclips	  etc.	  These	  will	  be	  posted	  on	  Wiley	  
Online	  Library	  with	  the	  article.	  The	  print	  version	  will	  have	  a	  note	  indicating	  that	  extra	  material	  is	  available	  
online.	  Please	  indicate	  clearly	  on	  submission	  which	  material	  is	  for	  online	  only	  publication.	  Please	  note	  that	  
extra	  online	  only	  material	  is	  published	  as	  supplied	  by	  the	  author	  in	  the	  same	  file	  format	  and	  is	  not	  
copyedited	  or	  typeset.	  Further	  information	  about	  this	  service	  can	  be	  found	  at	  
http://authorservices.wiley.com/bauthor/suppmat.asp	  
13.	  Early	  View	  	  
British	  Journal	  of	  Clinical	  Psychology	  is	  covered	  by	  the	  Early	  View	  service	  on	  Wiley	  Online	  Library.	  Early	  
View	  articles	  are	  complete	  full-­‐text	  articles	  published	  online	  in	  advance	  of	  their	  publication	  in	  a	  printed	  
issue.	  Articles	  are	  therefore	  available	  as	  soon	  as	  they	  are	  ready,	  rather	  than	  having	  to	  wait	  for	  the	  next	  
scheduled	  print	  issue.	  Early	  View	  articles	  are	  complete	  and	  final.	  They	  have	  been	  fully	  reviewed,	  revised	  
and	  edited	  for	  publication,	  and	  the	  authors’	  final	  corrections	  have	  been	  incorporated.	  Because	  they	  are	  in	  
final	  form,	  no	  changes	  can	  be	  made	  after	  online	  publication.	  The	  nature	  of	  Early	  View	  articles	  means	  that	  
they	  do	  not	  yet	  have	  volume,	  issue	  or	  page	  numbers,	  so	  they	  cannot	  be	  cited	  in	  the	  traditional	  way.	  They	  
are	  cited	  using	  their	  Digital	  Object	  Identifier	  (DOI)	  with	  no	  volume	  and	  issue	  or	  pagination	  information.	  Eg	  
Jones,	  A.B.	  (2010).	  Human	  rights	  Issues.	  doi:10.1111/j.1467-­‐9299.2010.00300
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Appendix 2: Quality criteria data collection sheet  
Study identification number: (Include author, title, year of publication, journal title, 
pages) 
Author(s):  
Title:  
Journal reference: 
Checklist completed by: 
Section 1: Study Rationale 
1.1 The study addresses an appropriate and clearly 
focused question. 
1 Yes 
0 No 
1.2 The main objective of the study is clearly 
defined 
1 Yes 
0 No 
Total score for section 1    /2 
Section 2: Selection of Subjects 
2.1 The sample is representative of the population 
being studies. 
1 Yes 
0 No 
2.2 The study reports the sample size.  1 Yes 
0 No 
2.3 The study indicates how many of the people 
asked to take part did so 
1 Yes 
0 No 
2.4 The study reports the retention rate for each 
stage of follow up 
1 Yes 
0 No 
2.5 Comparison is made between full participants 
and those lost to follow up. 
1 Yes 
0 No 
2.6 The study states the inclusion and exclusion 
criteria. 
1 Yes 
0 No 
Total score for section 2   /6 
Section 3: Assessment 
3.1 The outcomes are clearly defined. 1 Yes 
0 No 
3.2 The measure of assessment of outcome is 
stated and is reliable and valid 
2 well covered  
1 adequately addressed 
0 No, poorly addressed 
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Score for section 3   /3 
Section 4: Confounding 
3.1 The main potential confounders are identified 
and taken into account in the design and 
analysis. 
2 well covered 
1 adequately covered 
0 No, poorly addressed 
Score for section 4:   /2 
Section 5: Statistical analysis 
4.1 The statistical analysis is appropriate given the 
study design and the outcome measures used 
1 Yes 
0 No 
4.2 Are effect sizes, confidence interval and p-
values been reported where appropriate 
reported 
1 Yes 
0 No 
Score for section 5 /2 
Section 2: Overall assessment of the study 
Overall Total:    / 
Percentage:  % 
Quality rating: 
 
(Poor = <50%; Moderate=50-74%; Good= >75%) 
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Appendix 4: Major Research Proposal: the study of living kidney donor decision-
making and psychosocial outcomes	  
INTRODUCTION 
It is widely accepted that renal transplantation from a live donor poses the best outcome for 
individuals with end stage renal failure (ESRF) as the survival rate is higher and the kidney has a 
longer life span (Gjertson, 2003).  However, research examining the impact kidney donation has 
on the donor is limited.  Research to date concurs that kidney donors do not experience any long-
term medical complications following donation; the life expectancy of donors is similar to that of 
non-donors and the risk of ESRF does not increase (Ibrahim et al., 2009).  With respect to 
psychological health, initially the available literature concluded that live kidney donors have a 
highly positive experience with kidney donation and an enhanced self-esteem and self-regard 
related to this act.  This conclusion was drawn from several studies reporting that donors’ post-
operative psychosocial outcome scores on the Medical Outcome Study 36-item Short Form Health 
Survey (SF-36) indicated a higher or comparable quality of life to aged matched controls (Buell et 
al., 2005; Chen et al., 2004; Fehrman- Ekholm et al., 2000; Giessing et al., 2004; Johnson et al., 
1999; Perry et al., 2003).  However, more recently it has been argued that living kidney donors are 
a select sample of healthy individuals and therefore pre-donation their SF-36 scores are inflated in 
comparison to the general population (Walton-Moss et al., 2007).  Thus it is possible that donation 
impacts negatively on donors’ psychosocial health yet their SF-36 scores will still be comparable 
with population norms.  Therefore, in order to give an accurate description of the pace of recovery 
following donation and the psychosocial outcome of donation, a prospective study design in which 
the SF-36 scores are compared pre- and post- operatively is required.  
Data from prospective studies suggests that for the majority, kidney donation does not have a 
long-term clinical impact on physical and psychological health of donors.  For example, Wolf et al 
(2001) and Taghavi et al (2001) reported that donors’ pre- and post-operative scores on the SF-36 
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and the SCL-90 were similar.  Virzi et al (2007) reported a significant improvement in all SF-36 
scores with the exception of physical activities.  Lumsdaine et al (2005) reported that donors’ 
physical and psychological domain scores on the world health organization quality of life 
questionnaire showed a marked decrease 6 weeks after donation.  However, the authors concluded 
that living kidney donation did not have any long-term detrimental effect on the physical or 
psychological well being of donors.  This was mainly due to the finding that 12-month 
postoperative scores were equal to that of pre-donation and at all times remained higher or 
comparable with population norms.  Furthermore, there was no change in the donors’ social or 
environmental domain scores and the donors and recipient experienced a significant improvement 
in their mutual relationship.  By comparison, Smith et al (2004) reported a statistically significant 
decrease in the Mental Health Component Summary (MCS) score of the SF-36 with an effect size 
of –0.53 and –0.63 at 4 month and one year postoperative.  However, this change was clinically 
significant for just 19% of the population.  Whilst Smith et al (2004) found a statistically 
significant impact on the MCS score but not the Physical Health Component Summary (PCS) 
score, Bergman et al (2005) reported statistically significant changes in the PCS score but not the 
MCS score.  However, once again, for the majority of the sample this was not clinically 
significant.   
The impact of kidney donation on the psychiatric morbidity of donors remains unclear.  Where 
Virzi et al (2007) reported a significant reduction on depression and anxiety scores, Minz et al 
(2005) reported a significant increase and Tanriverdi et al (2004) reported lower depression scores 
on the BDI but increased prevalence of anxiety following donation.  By comparison, Smith et al 
(2004) reported that point prevalence of DSM-IV psychiatric caseness increased from 2% pre-
donation to 25% and 15% four and 1year postoperative respectively.  
Although for the majority, live kidney donation does not seem to have a long-term negative 
impact, a small proportion of donors have reported adverse psychosocial outcomes, regretted 
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donating, and described the experience as stressful (Fehrman- Ekholm et al., 2000; Isotani et al., 
2002; Johnston et al., 1999).  Understanding the factors that lead to poorer psychosocial outcome 
after donation for some individuals will inform the psychological screening of potential donors 
and post-operative follow-up of donors.  To date several factors that increase the risk of a poor 
psychosocial outcome have been identified.  Individuals who feel ignored or abandoned after 
donation (Brown & Sussman, 1982; Schover et al., 1997) or perceive poor recipient reciprocation 
(Minz et al., 2005) are more likely to report poor psychosocial outcomes.  Unsuccessful 
transplantation (Fisher et al., 2005; Hivvas et al., 1980; Isotani et al., 2002 and Johnston et al., 
1999) in particular recipient death (Minz et al., 2005 and Taghavi et al., 2001) leads to poorer 
psychosocial outcome.  Donors who perceive that their own health has been adversely affected by 
donation (Ozcurumez et al., 2004) or who have experienced persistent pain or prolonged 
hospitalisation (Minz et al., 2005) report poorer quality of life after donation.  Others report that 
the donation process itself does not directly affect their quality of life after donation but rather the 
donation process aggravates environmental stressors such as feelings of being unsupported 
(Varma et al, 1992) or existing marital discord (Smith et al, 1986) which in turn affects their 
quality of life.  
The stress experienced following medical procedures varies not only in accordance with the 
degree of intrusiveness, physical pain and discomfort but also in accordance with the perceived 
meaning of the procedure and the individuals coping style (Benyamini, 2007).  As such, there is 
extensive evidence to suggest a relationship between coping style and outcomes relative to 
physical and psychological health (Beutler et al, 2003).  Avoidant coping with the medical 
complaint, and the physical and psychological distress it causes, has been linked to negative 
outcomes such as increased pain in migraine suffers (Marlowe et al, 2003), poorer prognosis in 
cardiac patients (Kelsey & Leitten., 1996), increased relapse in psychiatric cohorts (Lemke & 
Moos, 2002 and 2003), increased risk of depression in the general population (Cronike &Moos, 
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1995), and poorer treatment outcome (Beutler et al., 2003).  By contrast, active coping has been 
linked with better outcomes in both adults (Rosenberger et al., 2004) and adolescents 
(LaMontagne et al., 2004).  The impact of coping style on psychosocial outcome following live 
kidney donation has not been investigated.  Identifying the link between coping style and 
psychosocial outcome following kidney donation is imperative to screening potential donors and 
post-operative counselling and thus represents an area where research is greatly needed.  
   AIMS AND HYPOTHESES 
AIMS 
 To investigate the post-operative quality of life of live kidney donors.  
 To investigate which variables predict post-operative psychosocial outcome.  To gather 
information regarding how individuals decide to become living kidney donors and how 
satisfied they are with their pre- and post-operative care. 
 To investigate whether the donor decision-making process and satisfaction with the 
donation process is affected by the type of donor-recipient relationship. 
HYPOTHESES 
 The postoperative psychosocial health of live kidney donors will not differ significantly 
from their pre-operative psychosocial health. 
 Coping style will mediate the relationship between the donor decision making process and 
quality of life after donation 
PLAN OF INVESTIGATION 
INCLUSION CRITERIA FOR PARTICIPANTS 
This study aims to include:  
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Live kidney donors who undergo a nephrectomy2 at Manchester Royal Infirmary, Western 
Infirmary Glasgow, St. James University Hospital, Leeds and Royal Infirmary of Edinburgh.  
 Can read and write in English 
 Are aged 18 years and above 
RECRUITMENT PROCEDURE 
Transplant coordinators are responsible for identifying a donor, providing support and education 
for the donor, all pre-donation assessments, for organising organ and tissue retrieval, ensuring 
transplantation runs smoothly and undertaking a post-operative assessment.  Therefore, as they 
represent the hub of the transplant team and have the most frequent contact with the donor, 
recruitment will take place via the transplant coordinator.  The recruitment procedure will be as 
follows: 
 Transplant coordinators will make patient information sheets available to all prospective 
kidney donors who fulfil inclusion criteria for the present study. 
 Prior to the nephrectomy3, individuals who wish to participate will sign a consent form and 
be given the donor questionnaire booklet 1 and a SAE for return to the principle researcher 
(YMcN)   
 The principle researcher will contact the renal unit to obtain an estimated date of 
transplantation.   
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 the removal of the kidney 
3 A discussion will take place with each site to decide at which appointment this will take place.  
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 Three months post-operation, the researcher will mail questionnaire booklet 2 and a SAE 
for return to the researcher.  
 At the end of the study each participant and transplant coordinator will be informed of the 
study’s findings.  
MEASURES 
Questionnaire booklet 1 (appendix 1) contains a patient information sheet, demographic form, 
consent form, a checklist and the following questionnaires: 
 The Donor Decision Control Scale 
The Donor Decision Control Scale is a three-item 5-point likert scale indicating the extent to 
which donors involve a family member(s) in their decision to donate.  Level one is a decision 
made independently by the donor; level two is a decision made by the donor after consulting with 
a family member(s); level three is a shared decision made by both the donor and a family 
member(s); level four is the donor relying on a family member(s) to make the decision after 
consulting with the donor; level five is the donor relying on a family member(s) to make the 
decision that the donor will donate.  The test-retest reliability for this scale in a prospective study 
of donor decision-making and outcomes was 0.76 (Walton-Moss et al., 2007). 
 The COPE 
The COPE is a self-report multidimensional coping inventory, which assesses the different ways 
in which individuals respond to stress.  It contains 13 conceptually distinct subscales.  Five 
subscales measure problem-focused coping, where individuals actively try to alter the stressful 
situation.  Five subscales measure emotion-focused coping, where an individuals’ actions are 
directed at regulating the emotional response to the stressor.  Three subscales measure other less 
useful, coping responses such as focusing on and venting of emotion, behavioural disengagement 
and mental disengagement.  
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The validity and reliability of the COPE has been tested by administering the COPE and several 
other personality questionnaires to 978 college students (Carver et al., 1989).  The concurrent 
validity test showed that the active coping and planning subscales on the COPE correlated 
significantly with scales of optimism, control, self-esteem, hardiness and Type A personality 
(r=0.20-0.32) and active coping was inversely correlated with trait anxiety (r=-0.25).  With respect 
to reliability the internal consistency coefficients (cronbach’s alpha) were 0.62-0.92.  Test-retest 
reliability was tested with a further 89 students (eight-week retest) and 166 students (six-week 
retest) with correlations between 0.42 and 0.77.  The correlation between the scale items was 0.02-
0.69, however this can be interpreted as supporting the opinion that the subscales are empirically 
distinct domains (Bowling, 2005).  
• The Medical Outcomes Study 36-item Short Form Health Survey (SF-36)  
The SF-36 is a multipurpose4 health survey measuring physical and mental health.  The Physical 
Health Summary (PCS) is comprised from the following four domains, physical functioning, role-
physical, bodily pain and general health.  The Mental Health Summary (MCS) is comprised from 
the following four domains, vitality, social functioning, role-emotional, and mental health.   
The results of the SF-36 can be presented as either two summary scores, the MCS score and the 
PCS score or as scores on each of the eight domains. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 The SF-36 is a generic measure and therefore does not target one specific age, disease or treatment group.  
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For a UK sample, Ware et al (1994) reported that the internal consistency reliability was 0.92 for 
the PCS and 0.89 for the MCS.  The test-retest reliability for an interval of two weeks was 0.89 for 
the PCS and 0.80 for the MCS.  
The SF-36 has rapidly become the generic health measure of choice and is widely used as a 
measure of broader health quality of life as it contain eight of the most frequently measured health 
concepts (Bowling, 2005).  Within in the renal transplant literature, the Short Form Health Survey 
is the most frequently used patient reported measure of quality of life (Butt et al., 2008), with 65% 
of the studies investigating the psychosocial outcome for live donors choosing this as their 
validated questionnaire and 73% of these relying on this alone to measure quality of life. Within 
these studies the SF-36 has been administered post operatively and the scores obtained compared 
to population norms or control groups.  However, recently Walton-Moss et al (2007) administered 
the SF-36 before nephrectomy and found that donors scored as much as 20% higher than the US 
population.  The authors recommend that studies need to compare donors health related quality of 
life before and after surgery to provide a more accurate report of psychosocial outcome.   
• Hospital Anxiety and Depression Scale (HADS) 
The HADS (Zigmond and Snaith, 1983) is 14-item self-report measure designed to screen for the 
presence of mood disorders in medically ill patients.  The concurrent validity of the scale was 
tested by comparing the results of a clinical assessment with the HADS scale results. This yielded 
significant correlations, 0.54 for anxiety and 0.79 for depression (Zigmond and Snaith, 1983).  The 
scale has also been shown to be a valid measure of the severity of mood disorders and therefore 
the repeated administration of this scale at subsequent visits to the clinic will provide useful 
information concerning progress. 
Questionnaire pack 2 (appendix 2) contains a checklist and the following questionnaires:  
 The Living Donor Survey  
	   -­‐	  145	  -­‐	  
The Living Donor Survey is designed to measure attitude toward living kidney donation, 
satisfaction with donation education, hospital care, care after discharge and health after surgery 
(Beavers et al., 2001).  In a study of donor decision-making and outcomes the internal consistency 
of the dimension that measured attitude to living donation was 0.75 using Cronbach’s alpha 
(Walton-Moss et al., 2007) 
 The SF-36  
As above.  
• HADS 
As above. 
DESIGN 
 
DATA ANALYSIS 
A one tailed t-test will compare donors’ pre- and post-operative SF-36  
With respect to the HADS, individuals who score eight or less on either scale will be defined as 
having no significant anxiety or depression.  Individuals who score between eight and eleven will 
be considered to be “doubtful cases.”  Individuals who score between eleven and twenty-one are 
considered to have anxiety or depression and will be termed “cases”.   A one tailed t-test will 
compare donors’ pre- and post-operative HADS scores.  
Mediation analysis will be conducted to assess whether the relationship between donor decision-
making and psychosocial outcomes is mediated by the individuals coping style.  Mediation is a 
hypothesized casual chain in which one variable affects a second variable that, in turn affects a 
third variable.  The intervening variable, Z, is called the mediator as it mediates the relationship 
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between the predictor variables, X, and the outcome variables, Y.  Mediation can be depicted in 
the following way: 
X               a                            Z  b   Y 
Paths a and b are called a direct effect but the mediation effect in which X leads to Y through Z is 
called the indirect effect.  This indirect effect represents the proportion of the relationship between 
X and Y that is mediated by Z.  
To test whether coping style mediates the relationship between decision making and psychosocial 
outcome following donation, three regression analyses will be conducted on each dimension of the 
SF-36.  The first regression will examine the relationship between the predictor (i.e. answers on 
the Donor Decision Control Scale) and the mediator (i.e. answers on the COPE).  The second, 
between the predictor and dependent variable (i.e. SF-36 scores) and the final regression, both the 
predictor and mediator on the dependent variable.  If mediation exists, the predictor should be 
significant in the first two regressions but not in the third (or significantly reduced, indicating 
partial mediation), whereas the mediator must be a significant predictor in the third regression  
JUSTIFICATION OF SAMPLE SIZE 
Participation rate 
There are 16 published studies investigating the psychosocial outcomes for live kidney donors 
using a prospective design.  Within these the percentage of eligible donors that agreed to 
participate in the study varies from 80% (Walton- Moss et al., 2007) to 100% (Aguiar et al., 2007; 
Minnee et al., 2008; Nejatisafa et al., 2008 and Sanner et al., 2005). Therefore the estimated 
minimum participation rate is 80%.  
Retention Rate 
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Of the 16 published studies, seven failed to report retention (Bergman et al, 2005; Kok et al, 2006; 
Minz et al, 2005; Simmons et al, 1982; Taghavi et al, 2001; Varma et al, 1992 and Yoo et al, 
1996).  The remaining studies and the reported retention rates are presented below.  As can be 
seen the retention rates for three months post surgery vary from 64.5% to 100%.  Therefore 
estimated minimum three month retention rate is 64.5%.  
Time elapsed since nephrectomy AUTHOR 
1 
week 
2 
weeks 
3 
weeks 
1 
month 
3 
months 
4 
months 
6 
months 
1 
year 
Walton Moss et al 
(2007) 
    64.5%    
Wolf et al (2001)       60%  
Smith et al (2004)      94%  94% 
Lumsdaine et al 
(2005) 
       82% 
Minnee et al (2008) 100% 100%  100% 100%  100% 100% 
Sanner et al (2005)   100%      
Virzi et al (2007)      100%   
Aguiar et al (2007)     90%    
Nejatisafa et al 
(2008) 
    84%  84%  
 
Statistical Power 
Smith et al (2004) measured the psychosocial outcomes for live kidney donors 4- and 12-month 
postoperative using a prospective design.  The effect size for the PCS score and the MCS score at 
four months was -0.35 and -0.63 respectively.  Thus assuming the convention of α= 0.05 and 
power of 0.8 the sample size required to detect a statistically significant difference between the 
baseline and three-month post operative PCS and MCS scores is 52 and 18 respectively. 
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For the 12-month follow-up, Smith et al (2004) reported the effect sizes for the domain scores.  
The effect sizes and the corresponding sample size required to detect a statistically significant 
difference, assuming power of 0.8 and at significance level 0.05 are presented below.   
SF-36 
Effect size 
Sample req. 
Physical functioning 0.22 130 
Role physical 0.42 37 
Bodily pain 0.4 41 
General health 0.35 52 
Vitality 0.69 15 
Social functioning 0.58 20 
Role emotion 0.82 11 
Mental health 0.31 66 
 
Recruitment 
Data concerning the number of live kidney transplants carried out in the financial year of 1st April 
2008 to 31st March 2009 is available from the UK Transplant Organisation (transplant activity 
report).  The number of live kidney transplants carried out in Glasgow, Edinburgh, Leeds and 
Manchester within this period was 36, 20, 40 and 54respectively.  Therefore basing recruitment on 
the figures for 2008-2009, 6 month recruitment period and participation would be as follows: 75 
potential participants, 60 recruited (based on an 80% participation rate) and 3-month follow-up 
data available for 39 individuals (based on retention of 64.5%).  Thus, the current study would 
have had enough power to detect a statistically significant difference in the MCS scores and the 
corresponding domains with the exception of the physical functioning, bodily pain and general 
health domains.  With respect to the PCS score and the physical functioning, bodily pain and 
general health domains  the study will have been able to report the number of individuals who 
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have a clinically significant difference as indicated by a difference of 10 or more points between 
the pre- and post operative score 
SETTING AND EQUIPMENT 
This study will not involve the use of equipment and it is not necessary to purchase the license for 
the questionnaires used in this study. 
HEALTH AND SAFETY ISSUES 
PARTICIPANT SAFETY ISSUES 
The transplant coordinator, who monitors the health of the donor following transplant, will be 
notified of any individual identified as requiring medical or psychological care.  They will then 
refer this individual to the appropriate psychological services attached to the renal unit.  The 
proposed sites have been selected because each has dedicated psychological input.  
The study will not screen for cognitive impairment or psychological morbidity but will rely on the 
screening processes of the renal unit.  The study aims to measures the pre- and post-operative 
psychosocial health of donors at each site and therefore it is essential the study does not alter the 
donation process in any way.  
 
If a participant has pre-operative psychological morbidity this will not affect the study outcomes, 
as analysis is focused on identifying postoperative changes in psychosocial health.  
FINANCIAL ISSUES 
A funding application has been made to the department of psychological medicine for the cost of 
two SAE envelopes per participant and the paper and photocopy costs of questionnaires. Travel 
costs to Manchester Royal Infirmary, Salford Royal Hospital and Royal Infirmary of Edinburgh 
have also been included.  Each of the proposed sites have agreed in principal to participate but 
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have requested a meeting in person so that I can meet with each member of the renal transplant 
team, answer questions and together we can agree a site specific methodology. Salford Royal 
Hospital does not carry out live kidney transplants, all live kidney transplants take place at 
Manchester Royal Infirmary. However, Salford Royal Hospital employs live kidney donor co-
ordinates to provide the pre- and post-operative care for those individuals who donate a kidney to 
a Salford Royal Hospital patient.   
As detailed in the attached Research Equipment, Consumables and Expenses form, the estimated 
total cost for this study will be £402.92. 
TIMETABLE 
 July 2009:  Submission of proposal to course   
 August: writing shortened version of proposal 
 August: Anticipate that feedback will be received by course.  
 September and October:  Applying for Ethics and R&D approval for Glasgow site. 
 September and October: With respect to Edinburgh and Manchester initially contact site by 
phone to obtain correct email addresses and consent to forward proposal, email shortened 
proposal and cover letter explaining study to appropriate staff, follow-up by telephone  
 November: start recruitment at Glasgow site. 
 November: cut-off date for recruiting Edinburgh and Manchester sites, R&D and ethics 
applications for additional sites 
 1st April 2010: stop recruitment donors 
 1st July: final follow-up assessment 
 July: write up. 
 
PRACTICAL APPLICATION 
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Understanding the medical and psychological outcomes for donors is crucial to guiding informed 
consent and also to the development of services that maintain the long-term health of donors.  
Therefore, the Institute of Medicine and several transplant organizations including the American 
Society of Transplant Surgeons, The Division of Transplantation of the Health Resources and 
Services Administration, and the National Institutes of Health have recommended that transplant 
centres collect data on the medical and psychological outcomes of live donors which can be 
provided to future individuals considering donation (Adams et al., 2002).  
The outcomes of this study will guide education of potential donors, inform potential donors of the 
risks and benefits of donation therefore promoting informed consent, assist in the psychological 
assessment of potential donors and help identify appropriate care after donation.   
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CHAPTER 3: ADVANCED CLINICAL PRACTICE I (COURSE 12):REFLECTIVE 
CRITICAL ACCOUNT 
Title: Learning to be mindful of negative automatic thoughts and their impact on behaviour 
in an anxiety provoking situation: Abstract  
 
Abstract 
This reflective account describes a time in which I presented to a group of medical students and 
was challenged by an Assistant Psychologist. Giving the presentation showed my supervisor and 
myself that I had the ability to present to other professionals and therefore meet an advanced 
competency for the placement. However the process of reflecting on this event provided the most 
valuable learning experience. Using Gibbs’ (1988) model of reflection, in this account I will detail 
my reflection during and after the presentation. Through this reflection I have learnt to be more 
mindful of my negative automatic thoughts and the impact that they can have on my behaviour 
and emotions. I learnt to understand others’ behaviour by making hypotheses about their thoughts 
and emotions. This reflection has better prepared me for becoming a newly qualified practitioner 
as I have learnt that I cannot change the behaviour of other professionals that I work with but I can 
behave in an assertive and professional manner whilst gathering evidence which undermines 
negative thoughts about my ability. I therefore feel more confident in my ability to implement the 
Continuing Professional Development guidelines which state that clinical psychologists should 
work with other professionals from their own and other agencies in order to meet the complex 
needs of their clients. 
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CHAPTER 4: ADVANCED CLINICAL PRACTICE 2 (COURSE 13):  REFLECTIVE 
CRITICAL ACCOUNT 
Learning to adapt clinical practice to meet the needs of ethnic minority communities to 
overcome health inequalities and to develop advance clinical competencies: Abstract  
ABSTRACT 
My second advanced clinical placement was within a Clinical Health Psychology Service 
which offered rehabilitation following a specific chronic illness (for confidentiality reasons the 
exact nature of the condition is not disclosed). It was widely accepted that South Asians living 
in the UK had a higher prevalence of this condition (British Heart Foundation, 2003) but were 
less likely to  engage with the appropriate rehabilitation services (Webster, 1997) . 
Government legislation stipulates that NHS Scotland must meet the needs of people from 
different cultural backgrounds (Race Relations Act 2000) and therefore the clinicians and the 
managers in this team were focused on developing the service to overcome this health 
inequality.  
Currently the Government is focusing on the provision of mental health services in order to 
achieve race equality in the NHS (Delivering Equal Services to Black and Minority Ethnic 
Communities in Scotland – Proposal for a Race Equality & Mental Health Programme: 2008-
2011). The National Occupational Standards (NOS) state that Clinical Psychologists must manage 
the provision of psychological systems, services and resources to meet customer requirements. 
Therefore as a Clinical Psychologist and as a member of this team, I had a responsibility to offer a 
service that met the needs of individuals from an ethnic minority culture.   
In this account I have used Kolb’s Learning Cycle (1984) and Gibbs’ Model of Reflection (1988)	  
to explore how I developed my competency in working with individuals from minority ethnic 
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communities through reflecting on my professional experience and the literature that I read. I 
reflect on how in an attempt to show an understanding and respect for a Muslim patient’s culture 
and faith I initially failed to use my core competencies in developing a therapeutic relationship, 
carrying out an assessment and establishing the patient’s thoughts and beliefs through Socratic 
questioning. However, though reflection-in-action and reflection-on-action I was able to go on to 
encourage my patient to engage with a service which she previously refused to engage in and 
provided a full course of Narrative Therapy with a planned discharge. 	  
